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ABSTRACT
ANTI-DIABETIC POTENTIALS OF PHENOLIC ENRICHED CHILEAN POTATO
AND SELECT HERBS OF APIACEAE AND LAMIACEAE FAMILIES
SEPTEMBER 2010
FAHAD SALEEM, B.S. UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Dr. Kalidas Shetty
The incidence of diabetes mellitus and cardiovascular diseases is increasing at a
worrisome rate globally. Diabetes mellitus is known to occur due to high blood glucose
levels, caused by defects in insulin levels. Adult on-set type II diabetes, which is closely
associated with obesity, is reported to be 90-95% of all diabetic cases and linked to diet
and lifestyle factors. A large population of the developed and developing countries is now
being effected by this epidemic. Natural sources of phenolic antioxidants and inhibitors
of digestive enzymes from food sources have potential for low cost dietary management
of type II diabetes. Therefore, the main focus of this study was to evaluate, develop and
design effective dietary strategies based on a combination of Chilean potatoes and herb
synergies for the management of hyperglycemia and hypertension linked to type II
diabetes.
Antioxidant, antihypertensive and anti-hyperglycemic potentials of Chilean potato
(Solanum tuberosum ssp. tuberosum L.), herbs from the Apiaceae (Dill, Ajowan, Fennel,
Caraway, Coriander and Anise) and Lamiaceae (Sage and Marjoram) families were
evaluated, with a goal to target a new dietary management strategy for early stages of
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type II diabetes through lowering of hyperglycemia and related complications of
hypertension
The results indicated a high correlation between total phenolic content and total
antioxidant activity in several Chilean potato varieties evaluated, which indicates that
certain phenolic compounds may be responsible for high antioxidant activity. Also,
certain varieties of Chilean potato had antihypertensive potentials, with ACE inhibition
upto 88%.
The α-glucosidase inhibition relevant for hyperglycemia management for
Apiaceae family ranged upto 50% (Dill) for aqueous extracts. A high correlation (r =
0.86) was observed between α-glucosidase inhibition and total phenolic content for
aqueous extracts of all species investigated in the Apiaceae family. A high rosmarinic
acid activity was observed in aqueous extracts of Lamiaceae family, which ranged upto
39.7 mg/g of sample dry weight (DW). This suggests that high phenolic content and
associated antioxidant activity found in sage and marjoram is dominated by rosmarinic
acid.
High enzyme inhibitory activities, reflecting in vitro anti-hyperglycemic and antihypertensive potentials indicates that consumption of these food sources in our diet
would prove to be beneficial towards our health. Further in vivo studies for type II
diabetes-linked functionalities of these natural sources of antioxidants and inhibitors
would confirm the human health benefits achieved through dietary intake.
Keywords: Angiotensin-I converting enzyme (ACE), Antioxidant Activity, αglucosidase, Chilean potato (Solanum tuberosum ssp. tuberosum L.), Apiaceae,
Lamiaceae, Phenolic Content, Rosmarinic acid
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CHAPTER 1

INTRODUCTION

Diabetes mellitus is now becoming a common metabolic disorder, resulting from
the inability of our body’s response to high blood glucose levels. Type II diabetes
mellitus is reported to be 90-95% of all diabetic cases (Schulze and Hu, 2005). The
epidemic nature of type II diabetes is closely associated with obesity, and according
to World Health Organization (WHO), more than 220 million people were suffering
from it in 2009 (WHO. www.who.org). The number of people projected to suffer
from type II diabetes is predicted to rise over 350 million by 2030 (Diet, nutrition and
the prevention of chronic diseases, www.who.org).
Remarkable progress has been achieved in development of synthetic drugs, but
investigations are being carried out to discover natural and cost-effective food sources
for managing hyperglycemia and hypertension associated with early stages of type II
diabetes, through diets rich in legumes, fruits, vegetables, herbs and spices. These
plant foods consist of basic nutrients such as vitamins, minerals, dietary fibers and
more important bioactive compounds such as polyphenols and carotenoids
(Montonen et al., 2004; Robert et al., 2006) that can have specific structure-function
benefits (Shetty et al., 2008; Pinto and Shetty, 2010). Consumption of these bioactive
enriched plant foods has the potential to prevent and lower the occurrence of early
stages of these chronic diseases such as type II diabetes, cardiovascular diseases and
their late stage complications. Many plant foods and specific varieties of specific
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species contain hypoglycemic compounds, acting as antimetabolites to help block
specific disease pathway, including the oxidation pathway of fatty acids (Ahmad et
al., 2009). Plant sources utilized as medicinal herbs and seeds are known to have low
toxicity levels and several therapeutic properties, due to which more recognition has
been given to them as being safer than synthetic drugs. Natural plant and food sources
provide α-amylase and α-glucosidase inhibitors, which plays a part in offering
techniques to control postprandial hyperglycemia (Kwon et al., 2006; Shetty et al.,
2008; Pinto and Shetty, 2010) with minimum side effects.
Herbs and seeds of many plant sources are being evaluated to measure their levels
of phenolic phyotchemicals, containing high antioxidant activity (Kwon et al., 2006).
Phenolic phytochemicals are used by plants to protect them from abiotic and biotic
stresses, but are equally also beneficial to preventing and combating human chronic
diseases linked to oxidative stress (Shetty and Wahlqvist, 2004). The presence of
certain phenolic compounds in plant foods are associated and highly correlated with
high antioxidant activities along with high amounts of α-amylase and α-glucosidase
inhibitors, which plays a role in the treatment of managing hyperglycemia and related
complications of hypertension (Kwon et al.,2006; Shetty et al., 2008; Pinto and
Shetty, 2010).
Therefore the aim of this thesis was to evaluate novel Chilean potato (Solanum
tuberosum ssp. tuberosum L.) widely used as potato-based foods in the tropical and
sub-tropical regions, as well as select species of the Apiaceae and Lamiaceae families
used as condiments for their anti-diabetic and anti-hypertensive potentials. A
synergistic combination of the right potato varieties with the right combination of
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condiments can be the basis of an effective dietary strategy for managing early stages
of type II diabetes, associated hyperglycemia and its oxidation-linked micro vascular
and macro vascular complications such as hypertension.
Potato originated from the Andean mountains (Andean potato – Solanum
tuberosum ssp. andigenum L.) and also Chiloe Islands (Chilean potato – Solanum
tuberosum ssp. tuberosum L.) of South America. Potato has been used as a food
source since ancient times, but is commonly perceived as an unhealthy food item due
to its high starch content and when fried with vegetable oils. It is amongst one of the
most highly produced crops and the third largest food crop consumed, following rice
and wheat (Camire et al., 2009). Phytochemicals in potato are often found in its peel,
and its content is higher in cultivars with brighter peel colors (Zhang et al., 2009).
Phytochemicals are relevant to human health in the form of antioxidants and associate
bioactive functions for specific disease conditions, and the high daily consumption of
potato could contribute a high phenolic content to our diet (Xu et al., 2009). Potato is
known to have a low fat content, therefore its consumption in substitution for other
high carbohydrate content foods such as rice and pasta may potentially benefit our
overall health. Chilean potato (Solanum tuberosum ssp. tuberosum L.) used as genetic
stock in developing tropical and sub-tropical varieties was chosen for the evaluation
of its health benefits, in relation to total phenolics, antioxidant activity and in vitro
enzyme inhibition assays (α-amylase, α-glucosidase and ACE), for potential
prevention and management of early stages of type II diabetes.
Plants and especially medicinal and food herbs have been used as traditional
medicine to treat common illnesses, since ancient times. Plants from the Apiaceae
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family are used as food, flavoring of foods and for their medicinal purposes, such as
stomachaches, abdominal pain and acidity (Shekhawat and Batra, 2006). Previous
studies have suggested that species belonging to the Apiaceae family have
hypoglycemic effects on humans and animals (Dhandapani et al., 2002). To develop
treatments for prevention of chronic illnesses, this study investigated the medicinal
uses and phytotherapies of seeds from select species of family Apiaceae. The
discovery of innovative ideas for the development of plant-based medicine and foodbased therapies would allow the availability of medicine at a lower cost compared to
synthetic drugs. We evaluated the seed extracts of Foeniculum vulgare (Fennel),
Anethum graveolens (Dill), Coriandrum sativum (Coriander), Trachyspermum
copticum (Ajowan), Carum carvi (Caraway) and Pimpinella anisum (Anise) for their
anti-diabetic potential. Evaluation of 6 select species of the family Apiaceae was done
using in vitro assays, which provides the biochemical rationale to potentially target
them for prevention of type II diabetes based on future animal and clinical studies.
Further it has been estimated that, presently, 80% of the world’s population relies
on the use of traditional medicine for healthcare purposes (Muthu et al., 2006).
Therefore, the awareness of specific herbs for medicinal use is becoming common for
treating chronic illnesses. Herbs in the family Lamiaceae are known to be a rich
source of phenolic antioxidants (Shetty, 1997; Kwon et al., 2006), which often
indicates a high correlation with α-glucosidase inhibitors and therefore have the
potential for prevention of hyperglycemia. Therefore another focus of this research
study was to evaluate two select species of Lamiaceae family, such as Origanum
majorana (Marjoram) and Salvia libanotica (Sage), for their hypoglycemic potential.
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Many plants from Lamiaceae family originated from Near East Asia, where they have
been used for food preservation and treatment of common illnesses as traditional
medicine and now widely used around the world (Shetty et al., 1995; Kwon et al.,
2006). Lamiaceae family herbs contain phenolic phytochemicals, which are linked to
potentially managing chronic oxidation linked diseases (Shetty, 1997), and contains
potential capacity to lower mortality rates of cancer (Velioglu et al., 1998). Therefore
evaluating in vitro functionality assays would provide a biochemical rationale for the
use of sage and marjoram in prevention of hyperglycemia and hypertension linked to
type II diabetes.
In this thesis study, total soluble phenolics and DPPH inhibition assay to
determine the total antioxidant activity and phenolic profile were evaluated to explore
the potential of Chilean potato (Solanum tuberosum ssp. tuberosum L.), select
Apiaceae family species and 2 Lamiaceae family species from the Near East region
for potential use in the dietary management of early stages of hyperglycemia and
hypertension. Specifically in vitro functionality assays such as α-amylase, αglucosidase and angiotensin-I converting enzyme (ACE) inhibitory activities were
performed to evaluate the potential of studied samples towards hyperglycemia and
hypertension management.
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CHAPTER 2

LITERATURE REVIEW

2.1

Hyperglycemia and Hypertension Linked to Type II Diabetes

The occurrence of type II diabetes is becoming a global epidemic which is
essentially due to dramatic changes in diet and lifestyle. Diabetes is known to occur
due to elevated blood glucose levels and the inability of a body’s response to high
blood glucose, which is caused by defects in insulin secretion, insulin action (Schulze
and Hu, 2005) and several other pathological changes. Diabetes mellitus is known to
be effecting people of both developed and developing countries, harming a large
percentage of the world’s population. Type II diabetes mellitus is reported to make up
90% - 95% of all diabetic cases. It develops when the cellular sensitivity to insulin
signaling is reduced (Schulze and Hu, 2005). Type I diabetes, which is caused due to
complete deficiency of insulin secretion, is due to the destruction of pancreatic beta
cells. It is believed that the reason behind increase in occurrence of type II diabetes is
due to environmental risk factors, and for type I diabetes there are only a few known
environmental risk factors that could potentially cause the disease (Schulze and Hu,
2005). Previous studies have suggested that the adoption of Western diet (Van Dam et
al., 2002), along with other risk factors such as obesity and the lack of physical
activity are associated with increased incidence of type II diabetes.
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The number of people suffering from type II diabetes is rising constantly
worldwide. Due to the increase from 35 million people with type II diabetes in 1985
(Schulze and Hu, 2005) to more than 220 million people in 2009 (World Health
Organization, www.who.org), we can assume that the epidemic nature of type II
diabetes is due to environmental risk factors rather than genetic changes. Genetic
background is unlikely to have changed the nature of type II diabetes due to the short
time period. The incidence of type II diabetes is closely related to the worldwide
epidemic of obesity, and the amount of people projected to have type II diabetes is
predicted to increase over 350 million by 2030 (Diet, nutrition and the prevention of
chronic diseases, www.who.org).
Cardiovascular diseases (CVD) are associated with type II diabetes as one of its
main consequence, and majority of people effected with type II diabetes die of
cardiovascular complications (Schulze and Hu, 2005). The risk of cardiovascular
diseases in patients with type II diabetes is 2-6 times higher than people without type
II diabetes (Gaede et al., 2003). Type II diabetes associated cardiovascular diseases
and high incidence of micro vascular and macro vascular complications is also the
leading cause of blindness, kidney failure and amputations (Gaede et al., 2003;
Schulze and Hu, 2005). The direct medical cost of diabetes and diseases linked with
diabetes is enormous, e.g., it was estimated to be over $132 billion in 2002 (Report
from the American Diabetes Association, 2002). The rise in economic spending for
type II diabetes is going to rise enormously, since the World Health Organization
predicted that there is going to be over 350 million people affected with type II
diabetes by 2030.
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There is no known cure for diabetes. Therefore bringing out awareness for
changing the diet and lifestyle through which the occurrence of such illnesses could
be reduced is the best strategy. There has been a remarkable progress and
development in the therapy of type II diabetes mellitus through synthetic drugs.
However, the investigation for anti-diabetic substances from natural sources for
management of hyperglycemia and hypertension linked to type II diabetes is being
pursued due to their lower toxicity and side effects (Ahmad et al., 2009; Pinto and
Shetty, 2010).
Plant-based foods used for medicinal therapies have been used since ancient times
to treat common illnesses. Recent studies have found activities of various plant foods
containing anti-metabolites that help prevent the oxidation pathway of fatty acids
(Ahmad et al., 2009), which has consequences for managing hypoglycemia. Natural
α-amylase and α-glucosidase inhibitors from food-grade plants provide dietary
strategies to control postprandial hyperglycemia, and the natural form of these
inhibitors could be used in therapies with minimum side effects (Kwon et al., 2006;
Shetty et al., 2008; Pinto and Shetty, 2010). Therefore, food-based biochemical
studies on bringing awareness towards managing hyperglycemia and hypertension
linked to type II diabetes through dietary management is gaining enormous
importance. The inclusion of diets rich in fruits and vegetables compared to diets
including red meat and sweets, independent of physical activity and family history of
diabetes, indicates a lower risk for type II diabetes (Van Dam et al., 2002). Therefore,
the diets rich in fruits and vegetables would also indicate a lower risk for
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cardiovascular complications, due to the high phenolic antioxidants and natural
enzyme inhibitors.

2.2

Chilean Potato (Solanum tuberosum ssp. tuberosum L.)

Potato belongs to the Solanaceae family, and originated from the Andean
Mountains (Andean potato – Solanum tuberosum ssp. andigenum L.) and Chiloe
Islands (Chilean potato – Solanum tuberosum ssp. tuberosum L.) of South America,
where it has been used as a food source for thousands of years (Raker and Spooner,
2002; Ames and Spooner, 2008). Potatoes (Solanum tuberosum ssp. tuberosum L.)
grown in the Chilean region, as well as from the region of Venezuela and Argentina
(Solanum tuberosum ssp. andigenum L.) are known as high yielding crops (Ames and
Spooner, 2008). It has been known that Chilean potato is evolved from crossing of
subspecies andigenum and an unidentified wild species (Grun, 1990; Raker and
Spooner, 2002). There have been no studies carried out to explore the potential
benefits of Chilean potato, in preventing and managing hyperglycemia and
hypertension linked to type II diabetes.
Potato (Solanum tuberosum L.) is a highly produced food crop in the world, and
the third largest food crop consumed, following rice and wheat (Camire et al., 2009).
Potato is commonly believed to be unhealthy due to its high starch and high
consumption when fried with oil, and many people are not aware of its health
benefits. Often, it is believed that potato consists of high caloric and fat content
compared to rice; which is incorrect since potato has a low fat and energy density,
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similar to legumes (Priestly, 2006; Camire et al., 2009). Consumption of potato in the
right amount, right high bioactive variety and with low processing could potentially
lead to the prevention of oxidation-linked chronic diseases such a type II diabetes and
cardiovascular diseases as opposed to its usual form of French fries and potato chips.
Fruits and vegetables consist of nutrients such as vitamins, minerals and dietary
fibers, as well as other bioactive compounds such as polyphenols and carotenoids
(Montonen et al., 2004; Robert et al., 2006), which are beneficial towards human
health (Shetty et al., 2008). Consumers are becoming more aware of the nutritional
benefits such as high antioxidant activities from fruits and vegetables than ever
before. Phytochemicals and specifically secondary metabolites like phenolics are
produced by plants to protect themselves from abiotic and biotic stresses, but they
could also potentially prove to be beneficial to manage human chronic diseases
induced under oxidative stress for high calories and life style changes (Shetty and
Wahlqvist, 2004).
The peel of potato is a good source of phytochemicals such as anthocyanins, and
its content is higher in potatoes with brighter peel colors (Zhang et al., 2009).
Anthocyanins are also known to have other biological functions such as high
antioxidants, antimicrobial and anti-obesity capacities (Zhang et al., 2009), and the
presence of anthocyanins in potato peel is 3-4 times higher than in the tuber.
Phytochemicals are associated to human health in the form of antioxidants, and are
associated with disease prevention abilities. Potato is usually not considered as a food
item with high antioxidant activity, but due to its high daily consumption, it is known
to contribute high total phenolic content to our diet (Xu et al., 2009). The high
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amount of antioxidants consumed through inclusion of potato in out diet could be
related to efficiently helping defend our bodies from cardiovascular diseases, by
limiting oxidative stress (Chu et al., 2002; Robert et al., 2006).
A important vitamin obtained from fruits and vegetables beneficial for human
health is vitamin C, and potato is rich in vitamin C with the content of 15 mg/100 g of
steamed potato (Robert et al., 2006). The amount of vitamin C in a potato contributes
to 25-30% of our daily recommended dietary allowance (Robert et al., 2006). Pinto et
al (2008), suggested that the presence of α-glucosidase inhibitors from certain plant
foods contributes to management of hyperglycemia linked to type II diabetes. Since
90% of the diabetic patients are suffering from type II diabetes, it is important that
dietary α-glucosidase inhibitors are present, to prevent the absorption of glucose in
small intestine (Ranilla et al., 2010). Therefore, type II diabetes could potentially be
controlled via inhibition of α-glucosidase enzyme, which participates in digestion of
carbohydrates. Potato varieties that have high α-glucosidase inhibitors can further be
used in vivo experiments as part of a therapeutic strategy, for management of
hyperglycemia linked to type II diabetes. Another inhibitor related to α-glucosidase
inhibitor is α-amylase inhibitor, which is also known to play an important role in the
management of hyperglycemia linked to type II diabetes (Pinto et al., 2009). The
inhibitory activities of these two enzymes are often linked to certain phenolic
compounds present in plant foods. Therefore, the inhibition of these enzymes could
vary by being high or low depending on the presence of phenolic phytochemicals that
enhance their activities in species specific plant species and varieties (Kwon et al.,
2006; Pinto et al., 2009). It has been suggested that inhibition of both α-glucosidase
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and α-amylase necessarily does not have to be present to help manage
hyperglycemia, as long as one of the inhibitor types show a high activity (Pinto et al.,
2009). However foods with high α-glucosidase inhibitor and low or medium αamylase inhibitor are considered ideal to avoid digestive complications from
undigested starch (Kwon et al., 2006).
Cardiovascular diseases are one of the leading causes of death in the
world, and type II diabetes increases the susceptibility to cardiovascular diseases due
to micro vascular and macro vascular complications. Diets rich in fruits and
vegetables

are

recommended

for

hypertension

management,

along

with

hyperglycemia linked to type II diabetes (Bazzano et al., 2003). The combination of
micronutrients, antioxidants, phytochemicals and fibers present in fruits and
vegetables also help reduce the overall risk of cardiovascular diseases (Liu et al.,
2000). An important target for managing vascular complications includes angiotensin
converting enzyme inhibition, which is used for treating hypertension associated with
congestive heart failures. Angiotensin I-converting enzyme (ACE) regulates vascular
hypertension by two different reactions (Johnston, 1992; Pinto et al., 2009). One way
is to convert angiotensin I into a vasoconstrictor, angiotensin II, and vasodilator
bradykinin that helps lower blood pressure (Johnston, 1992).
The different phenolic compounds from potato could be correlated with high or
low ACE inhibitory activity. This would indicate the potential of regular intake of
phenolic compounds through our diet for beneficial effects on cardiovascular system.
Chlorogenic acid forms 90% of the total phenolic compounds in potato tuber (Dao
and Friedman, 1992), which ensures the quality and safety of potato plant.
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Chlorogenic acid has the ability to lower blood pressure in hypertensive patients, and
its derivative has shown to lower blood pressure in hypertensive rats (Cheplick,
2010). Potato is also a good source of ferulic acid, supplying 5-70 mg/ 100 g, and a
source of dietary antioxidant to prevent vascular complications and type II diabetes
(Zhao et al., 2008). Another compound often observed in potatoes include caffeic
acid, which is a natural antioxidant abundant in plant foods, and has been proven to
be beneficial in cardiovascular complications by indicating hypotensive effects in
hypertensive rats (Li et al., 2005). Catechin activity in potato indicates the prevention
of type II diabetes (Matsui et al., 2007), cardiovascular complications and cancer
prevention abilities (Nagao et al., 2007). The inclusion of catechins through
consumption of potato, especially in high amounts is known to reduce fat, cholesterol
levels and blood pressure (Nagao et al., 2007).
Therefore, the inclusion of whole potato in our diet, not in its usual form of
French fries and potato chips, has potential health benefits by managing
hyperglycemia and hypertension linked to type II diabetes.

2.3

Apiaceae (Carrot) Family

The use of plant food sources and especially food herbs in traditional
medicine has increased the interest in exploring their beneficial effects on human
health. An estimated 70% of population globally utilizes traditional medicine
obtained from plants to treat and cure various ailments (Jiofack et al., 2009). Plants
from the family Apiaceae (Carrot) are commonly used as food, flavoring of foods and
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for their medicinal purposes. In particular, the seeds from family Apiaceae are known
to be used as a household remedy for complications such as hypertension (Gilani et
al., 2005). In other regions of the world such as India, plants from family Apiaceae
are used to treat common ailments such as stomachaches, abdominal pain and acidity
(Shekhawat and Batra, 2006). In India, a mixture of various plants is often consumed
orally with water, or applied externally by massaging the abdomen with it
(Shekhawat and Batra, 2006). In other parts of the world such as Cameroon, the use
of plants from Apiaceae family are targeted in therapies for vomiting, appendicitis,
ingestion, constipation and to treat mosquito bites (Jiofact et al., 2009).
Another ancient form of traditional medicine is known as ‘Ayurveda’, which uses
the active ingredients from plants in treating various illnesses (Dhandapani et al.,
2002). The use of plants is due to their less toxic, as well as more free from side
effects compared to synthetic products. Several plants belonging to the Apiaceae
family are considered to have hypoglycemic effects on humans and animals
(Dhandapani et al., 2002). The hypoglycemic effects of plants could possibly be due
to insulin affect, either by increasing pancreatic secretion of insulin from the cells of
islets of Langerhan’s or its release from bound insulin (Prasanna, 2000; Dhandapani
et al., 2002).
Various beneficial effects have been observed for seed extracts belonging to the
Apiaceae family, and following are the select species evaluated. Essential seed oils
form Foeniculum vulgare (Fennel) such as anethole and limonene are used for
medicinal purposes, and the seeds are also used as tranquilizers and tonics (Oktay et
al., 2003). Aqueous extracts of fennel seeds are observed for their hypotensive effects
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in a dose related manner (Oktay et al., 2003). Anethum graveolens (Dill) and
Trachyspermum copticum (Ajowan) seed extracts have been used to treat diarrhea,
ingestion and common colds (Husain et al., 2008), and Dill is also fed to cows and
goats for improving milk production (Lans et al., 2007). Ajowan seed oils have been
suggested to treat medical problems affecting joints or painful muscle conditions
(Husain et al., 2008). Coriandrum sativum (Coriander) seeds are often used as food
flavoring agent and to treat ulcers (Husain et al., 2008). Carum carvi (Caraway) plant
is beneficial in treatment and management of type II diabetes and cardiovascular
diseases, and evokes beneficial effects on elevation of lipids in the bloodstream
(Lemhadri et al., 2006). Pimpinella anisum (Anise) belongs to the Middle Eastern
region, where it is used as an aromatic spice and to help in digestion (Arslan et al.,
2004).
Phenolic antioxidants are attributed to the therapeutic use of medicinal plants in
managing hyperglycemia, by playing a part in causing delay in development of type
II diabetes. High content of polyphenols and vitamins due to high total phenolic and
total antioxidant activity, gives an excellent rationale for using plant sources for
medicinal purposes. It has been suggested that the high antioxidant activity potential
is often due to certain phenolic compounds (Kesilova et al., 2006). The usefulness of
antioxidants in our diet could be described by slowing down the oxidation of fats
(Yen and Duh, 1994), as well as being identified as free radicals or active oxygen
scavengers (Oktay et al., 2003). The inclusion of antioxidants in our diet by various
food sources could lead to weight loss, controlling obesity which is linked to type II
diabetes. Natural sources of antioxidants have the capability to protect against free
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radicals and chronic diseases (Oktay et al., 2003), whereas synthetic sources of
antioxidants are restricted due to their carcinogenicity (Zheng and Wang, 2001).
The use of natural herbal medicine for the prevention of blood pressure and type
II diabetes is practiced worldwide (Loizzo et al., 2008). The α-glucosidase inhibition
for select species of family Apiaceae suggests that, it would delay the degradation of
oligosaccharides, decreasing the absorption of glucose, which would inhibit the
increase in postprandial hyperglycemia (Loizzo et al., 2008). The high α-glucosidase
inhibitory activity is often associated with high total phenolic content and antioxidant
activity, which suggests that certain phenolic compounds are responsible for this
action. Compared to α-glucosidase inhibitory activity being associated with either
total phenolic content or antioxidant activity, it has been suggested that high αamylase inhibition is not linked to either of these activities (Cheplick et al., 2010).
Excess α-amylase inhibition could lead to stomach distention and discomfort, even
though α-amylase inhibitory activity has positive effects on prevention of
hyperglycemia, linked to type II diabetes (Cheplick et al., 2010). Since Apiaceae
family consists of moderate α-amylase inhibition and good α-glucosidase inhibition,
it is considered a good candidate for managing early stage hyperglycemia linked to
type II diabetes.
Hypertension is a known risk factor for various vascular complications, associated
with long term diabetes (Kwon et al., 2006). Type II diabetes plays a part in elevating
plasma lipids, which serves as a risk factor for coronary heart diseases (Chatterjea and
Shinde, 1994; Dhandapani et al., 2002). The risk of vascular complications could be
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decreased by lowering of plasma lipid levels by dietary strategies (Kanne and McGee,
1976; Scott, 1999; Dhandapani et al., 2002).
ACE inhibitory activity was not indicated for the family Apiaceae, which could
be due to the absence of certain phenolic compounds. Phenolic profile analysis by
HPLC helps recognize the phenolic phytochemicals in certain foods. Caffeic acid is
known to be present in fruits and vegetables, and have anti-inflammatory and
antioxidant properties (Son and Lewis, 2002). The presence of this compound in
select species of Apiaceae family suggests its disease prevention potential for type II
diabetes and vascular problems. The anti-cancer and antioxidant activities of phenolic
compound, catechin, has attracted attention due to its benefits on human health. It is
known that the ingestion of catechins is supposed to decrease waist size while
reducing body fat (Nagao et al., 2007), and helping to slow down the incidence of
type II diabetes by managing hyperglycemia. Rutin content is high in Apiaceae
family, and it is known to have special effects on dilating blood vessels and
improving interpenetration of veins (Wand et al., 2003). Rutin is a compound found
in many kinds of plants, and it is reported to consist of anti-inflammatory and
antioxidant activities. Its antioxidant activity is accountable for preventing oxidative
stress in pancreatic beta cells (Heineke et al., 1993), (preventing the uncontrolled
proliferation of damaged pancreatic beta cells, not resulting in diabetes). The
presence of rosmarinic acid suggests that it could be targeted against the production
of oxidation-linked diseases (Shetty and Wahlqvist, 2004). The presence of all the
above phenolic compounds indicates that Apiaceae family has the ability to provide
protection against oxidation linked diseases.
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Food designs and medicinal formulations using seeds from Apiaceae family and
incorporating them into the use for therapeutic purposes would prove to be beneficial,
due to its hyperglycemic inhibitory activities, linked to type II diabetes.

2.4

Lamiaceae (Mint) Family

Many plants related to Lamiaceae family have been originated from the
Middle Eastern region in Asia. Origanum majorana (Marjoram) and Salvia libanotica
(Sage) belongs to Lamiaceae (Mint) family, and also includes plants such as rosemary
and lavenders. Salvia is genera of plants considered to be widely diverse in Turkey,
and used as traditional medicine to treat common colds and stomach disorders
(Cuvelier et al., 1996). Water extracts of Salvia libanotica (Sage) in Middle East are
used to treat common colds, coughs and as anti-inflammatory agents in the oral cavity
(Farhat et al., 2001). Also, Origanum majorana (Marjoram) is rich in essential oils,
characterized for high amount of phenolic compounds. In Middle East, marjoram is
used as folk medicine particularly in the form of tea, prescribed for fever, sinus
congestion, as well as used to treat nervous disorders (Qari, 2008). Previous studies
have indicated that essential oils from sage and marjoram have antibacterial,
antimicrobial and suppressive activities against tumor formation (Hilan et al., 1997;
Farhat et al., 2001). Marjoram is important as it consists of anti-hepatoma and antigenotoxicity activities; reducing the number of cell and chromosomal aberrations
(Qari, 2008). The characteristics of sage and marjoram observed through various
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studies have determined their importance in preventive role for managing type II
diabetes.
Herbs from Lamiaceae family are also commonly used for food preservation,
culinary flavors and treatment of common illnesses as traditional medicine (Kwon et
al., 2006). Lamiaceae herbs are rich sources of phenolic phytochemicals and
antioxidants (Kwon et al., 2006); which are highly correlated with α-glucosidase
inhibitors, playing a potential role in hyperglycemia management. Plants belonging to
Lamiaceae family are great sources of natural antioxidants, often used as spices and
aromatic herbs. Therefore phenolic phytochemicals from Lamiaceae family in general
have potential for managing chronic oxidation linked complications, such as
cardiovascular diseases and type II diabetes (Shetty, 1997; Kwon et al., 2006). The
antioxidant activity associated with phytochemicals is also linked potentially to
lowering mortality rates of cancer in humans (Veioglu et al., 1998).
When considering suitable extracts, possible reason for higher phenolic content
determined for aqueous extracts is due to high temperature during sample preparation,
compared to ethanolic extracts (Seaberg et al., 2003; Chun et al., 2005). High
concentration of phenolic phytochemicals observed for oregano confirms its high
antioxidant and antimicrobial activity (Chun et al., 2005). High antioxidant activity
associated with total phenolic content, allows the consumption of sage and marjoram
in our diet to delay, or prevent the oxidation of lipids by inhibiting the propagation
and oxidizing chain reaction (Zheng and Wang, 2001; Chun et al., 2005). The dietary
phenolic antioxidants found as natural food sources, are important for delaying the
development of chronic diseases, such as cardiovascular complications and cancers
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(Shetty, 1997; Akyon, 2002; Chun et al., 2005). The antioxidant activity of phenolic
compounds may not be mainly due to phenolic content, but may be due to the redox
properties, physico-chemical structure and nature of the individual phenolics
(Kahkonen et al, 1999; Zheng and Wang, 2001; Parejo et al., 2002; Chun et al.,
2005). The potential of plant-based additives from sage and marjoram to prevent
oxidative stress proves that, the substitution of natural plant extracts for synthetic
source of antioxidants also have the potential to influence human health (Hinneburg
et al., 2006; Martinez-Tome et al., 2001). These herbs have the potential to be
industrially efficient due to their high phenolic antioxidants, slowing down the
oxidative degradation of lipids (Wojdylo et al., 2007), and improving the quality and
nutritional value of food. Pancreatic beta cells are damaged due to oxidative stress
before they are proliferated. If damaged pancreatic beta cells are prevented from
proliferating through cell repair or apoptosis, the possibility of incidence of diabetes
could be reduced. The high antioxidant activity potentially suppresses the oxidative
stress caused to pancreatic beta cells, reducing the risk of diabetes (Song et al., 2005;
Bhandari et al., 2008). Therefore, plants from Lamiaceae family with high phenolic
antioxidants could prevent the occurrence of diabetes, applied through dietary
management strategies in early stages.
The incidence of type II diabetes is growing at a worrisome rate, mainly due to
diet and lifestyle adopted in the developed and developing countries. Therefore,
therapeutic approaches including food based plants as medicinal sources are being
developed for prevention of chronic illnesses. Decreasing the risk of postprandial
hyperglycemia through a therapeutic approach can be achieved by slowing the
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absorption of glucose, by inhibiting α-glucosidase enzyme in the digestive organs
(Bhandari et al., 2008). Lamiaceae herb samples containing certain phenolic
compounds such as rosmarinic acid, caffeic acid and rutin may have hypoglycemic
effects, due to high α-glucosidase inhibitory activities. The consumption of
Lamiaceae herbs as condiments would result in enhancement of our health, due to
their potential health benefits in terms of α-glucosidase inhibition relevant to
hyperglycemia linked to type II diabetes. Inclusion of these herbs in our diet would
potentially reduce blood glucose concentration and lengthen the duration of
carbohydrate absorption (Ye et al., 2002). This would serve to be important because
lowering of the blood glucose level to normal is the most important part of treating
persistent hyperglycemia, which is the characteristic of diabetes (Ye et al., 2002).
Hypertension is a risk factor for formation of cardiovascular complications,
related to long term diabetes (Kwon et al., 2006) and was investigated to explore the
Lamiaceae species in this study. Further the phenolic compound often found to be
abundant in plant sources, especially in Lamiaceae family is rosmarinic acid
(Peterson and Simmonds, 2003) and could indirectly benefit hypertension
management. Rosmarinic acid contains high antioxidant activity, providing protection
against oxidation linked illnesses in general (Peterson and Simmonds, 2003), which
could be the reason for high antioxidant activity generally seen for sage and
marjoram. The presence of rosmarinic acid in plants belonging to Lamiaceae family
would prevent and manage hyperglycemia associated and linked to obesity. Further in
vivo studies would be essential for understanding the benefits of consuming
rosmarinic acid-enriched herbs on human health. Caffeic acid is a phenolic compound
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which plays an important part in fruits and vegetables as an antioxidant. Rutin is a
phenolic flavonoid found in many fruits and vegetables, which is used to provide
protection against development of vascular diseases (Schramm and German, 1998).
The presence of rutin would give us some evidence that targeting sage could be used
to benefit human health by managing hypertension, linked to type II diabetes.
Clinical information on the functions of sage and marjoram from Lamiaceae
family could be further applied in vivo studies for development of innovative
ingredient designs and formulations, for therapeutic strategies, to prevent chronic
illnesses associated with type II diabetes and its complications.

22

CHAPTER 3

OBJECTIVES

3.1

Chilean Potato (Solanum tuberosum ssp. tuberosum L.)

(a)

To study the phenolic-linked anti-diabetic potential of 54 subtropical cultivars of Chilean potato.

(b)

Study

the

α-Glucosidase,

α-Amylase

and

Angiotensin-I

Converting Enzyme (ACE) inhibitory activities.

(c)

To

screen

antioxidant,

anti-hypertensive

and

anti-diabetic

potentials.

(d)

Determine functionalities of potato for better dietary management
and future cultivar recommendation for potentially managing early
stage type II diabetes through diet.
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3.2

Apiaceae (Carrot) Family

(a)

To study the medicinal uses and phytotherapies of six select
species from Apiaceae family with a focus on their seeds.

(b)

To investigate the functionalities of select species and how their in
vitro effects could provide the biochemical rationale to potentially
target them towards prevention of type II diabetes.

(c)

Evaluate total soluble phenolics and DPPH inhibition assay to
determine the total antioxidant activity and phenolic content of
seeds.

(d)

Study in vitro assays such as α-glucosidase, α-amylase and ACE
inhibitory activities to evaluate seeds potential treatment of
hyperglycemia and hypertension management.
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3.3

Lamiaceae (Mint) Family

(a)

To screen two species (Origanum majorana and Salvia libanotica)
belonging to the Lamiaceae family from Near East Asia.

(b)

Evaluate in vitro assay such as total soluble phenolic and inhibitory
assays such as DPPH, α-glucosidase, α-amylase and ACE.

(c)

To provide the biochemical rationale for use of sage and marjoram
in prevention of hyperglycemia and hypertension linked to type II
diabetes.

(d)

To determine individual phenolic compounds found through HPLC
analysis of phenolic phytochemicals, allowing us to correlate the
phenolic compounds of the herbs to total antioxidant activity and
total phenolics content.
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CHAPTER 4

ANTI-HYPERTENSIVE AND ANTI-HYPERGLYCEMIC MANAGEMENT

4.1
Evaluation of Cultivars of Chilean Potatoes (Solanum tuberosum ssp.
tuberosum L.) for Diabetes and Hypertension Management Potential Using In Vitro
Models
4.1.1

Abstract

The rate of type II diabetes is increasing globally at a worrisome rate,
especially due to high rates of obesity. Water extracts of 54 different Chilean potato
(Solanum tuberosum ssp. tuberosum L.) varieties were evaluated for total phenolics and
antioxidant activity by 2, 2-diphenyl-1-picrydrazyl (DPPH) radical scavenging assay. In
vitro functionality assays such as inhibition of α-glucosidase and α-amylase relevant for
anti-hyperglycemia potential and angiotensin I-converting enzyme (ACE) for antihypertension potential were evaluated. The total phenolic content ranged from 0.92 mg/g
(PA 43) to 13.1 mg/g (PA 4) of sample dry weight. A high correlation (r = 0.83) was
observed for total phenolics and antioxidant activity by DPPH assay. Moderate activity of
α-glucosidase inhibition was observed in several varieties with no α-amylase inhibitory
activity. The anti-hypertensive potential of Chilean potato was high in select varieties,
with the line PA 17 having 88% ACE inhibition. These in vitro assays indicate that subtropical cultivars of Chilean potatoes have anti-hyperglycemia and anti-hypertensive
potentials, which could be part of breeding lines to develop whole potato food products
for effective diet designs. These diet designs based on animal and clinical studies can be
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targeted for managing early stages of type II diabetes when glucose management and
exercise can help better manage overall state of this chronic disease.

27

4.1.2

Practical Applications

In this study, we evaluated 54 sub-tropical Chilean potato (Solanum tuberosum
ssp. tuberosum L.) varieties to determine their relevance in managing hyperglycemia and
hypertension relevant for type II diabetes using in vitro models. This study established
that some Chilean potato varieties have the potential to manage hypertension and
hyperglycemia. The whole potato food products from such varieties could be part of food
designs and could be part of effective breeding programs to develop potato varieties with
health potential. This research gives us biochemical rationale for further in vivo animal
and clinical studies based on the in vitro enzyme assay models. This study can potentially
provide us with strategies to develop new food designs based Chilean potato breeding
stocks which can be parts of diverse diet designs with more effective potential for
reducing hypertension and hyperglycemia linked to type II diabetes.
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4.1.3

Introduction

Consumption of diets rich in fruits and vegetables are associated with lower
occurrence of type II diabetes and cardiovascular diseases, which are supported by
several biological and nutritional reasons. Fruits and vegetables consist of nutrients such
as vitamins, minerals and dietary fibers, as well as other bioactive compounds such as
polyphenols and carotenoids with potential health benefits (Montonen et al., 2004; Shetty
and Wahlqvist, 2004; Robert et al., 2006; Shetty et al., 2010).
Several studies have indicated that the current global diabetes epidemic is due to
dramatic changes in diet and lifestyle. Diabetes results from elevated blood glucose levels
which are caused by defects in insulin production and secretion in response to glucose
from dietary sources. Type II diabetes is reported to be 90%-95% of all diabetic cases,
and it develops when the production of insulin is insufficient to overcome the underlying
abnormality of increased glucose from the diet leading to increased resistance to its
action (Schulze and Hu, 2005)). According to World Health Organization, in 2009 more
than 220 million people were affected with type II diabetes, and the diabetes epidemic is
closely related to the worldwide epidemic of obesity (World Health Organization,
www.who.org). The 220 million people currently living with type II diabetes is predicted
to increase to over 350 million by 2030 (Diet, nutrition and the prevention of chronic
diseases, www.who.org).
Potato belongs to the Solanaceae family and originated from the Andean
mountains (Andean potato - Solanum tuberosum ssp. andigenum L.) and Chiloe Islands
(Chilean potato - Solanum tuberosum ssp. tuberosum L) of South America, where it has
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been used as a food source for thousands of years. It is commonly believed that potato is
unhealthy due to its high starch content and oil content when fried, and many people are
not aware of its health benefits from a range of other nutritional compounds such as
vitamins and bioactive phenolics., Potato is known to be one of the highly produced
starch crops in the world for quick source of calories, and third largest food crop
consumed in the world following rice and wheat (Camire et al., 2009). Potatoes are a
good source of starch when consumed in whole food form with energy density similar to
legumes (Camire et al., 2009; Priestly, 2006) with additional potential from bioactive
phenolic antioxidants.
Today, consumers are more aware of health benefits of antioxidants from fruits
and vegetables than ever in addition to their nutritional benefits from minerals and
vitamins. Phytochemicals and secondary metabolites like phenolics are produced by
plants to protect it from abiotic and biotic stresses, but they are also beneficial to humans
under disease induced oxidative stress (Shetty and Wahlqvist, 2004). Anthocyanins are
phenolic phytochemicals that are typically found in the peel of potatoes, and its content is
higher in cultivars that consist of brighter peel colors (Zhang et al., 2009). Antoxidant
phytochemicals are known to have disease prevention abilities which are associated with
overall human health. Generally, potato is not considered a high antioxidant containing
food based on refined starch products, but due to its high daily consumption from whole
food form and products it is known to contribute high total phenolic content to our diet
(Xu et al., 2009).
Increased carbohydrates and its conversion to fat in addition to fat intake have
been suggested to promote weight gain and obesity, contributing to type II diabetes. High
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fat intake in diet may also cause insulin resistance, independent of obesity (Diet, nutrition
and the prevention of chronic diseases, www.who.org). Addition of potatoes in whole
food with low deep frying to our diet compared to other high content carbohydrate foods
such as rice and pasta may benefit our health due to its lower fat content. In addition
factors such as enhanced physical activity with reduced smoking and consumption of
alcohol are known to reduce the risk of type II diabetes by maintaining a healthy body
weight and lifestyle.
Therapeutic and clinical strategies that manage type II diabetes is through the
reduction of glucose by decreasing starch hydrolysis via blocking the pancreatic αamylase (Pinto et al., 2009). Also, α-glucosidase enzyme is used to prevent intestinal
glucose absorption with dietary strategies being potentially safer (Kwon et al., 2006). The
natural forms of α-glucosidase and α-amylase inhibitors that we ingest through our daily
diet have potential to prevent hyperglycemia helping manage the incidence of type II
diabetes. Angiotensin I-converting enzyme (ACE) regulates vascular hypertension via
two different reactions (Johnston, 1992; Pinto et al., 2009). One way is to convert
angiotensin I into a vasoconstrictor, angiotensin II, and vasodilator bradykinin that helps
in lowering blood pressure (Johnston, 1992). Hypertension could be enhanced due to
occurrence of type II diabetes; therefore, the inhibition of ACE could be helpful in
decreasing hypertension linked to complications of type II diabetes. Therefore, the main
objective of this study was to evaluate health benefits of Chilean potato (Solanum
tuberosum ssp. tuberosum L.), in relation to total phenolics, antioxidant activity by DPPH
and in vitro enzyme inhibition (α-amylase, α-glucosidase, and ACE) for potential

31

reduction of hyperglycemia and hypertension for overall dietary management of type II
diabetes.
The phenolic-linked anti-diabetic potential of 54 sub-tropical cultivars (varieties)
of Chilean potato was evaluated. The screening of health-linked functional potential in
these potato cultivars can help us to make cultivar recommendation and better varieties
for potentially managing early stage type II diabetes through diet.
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4.1.4

Materials and Methods

4.1.4.1 Materials
Dried samples of 54 different cultivars of sub-tropical Chilean potatoes
(Solanum tuberosum ssp. tuberosum L.) were received from Puerto Montt, Chile. Porcine
pancreatic α-amylase (EC 3.2.1.1), rat intestinal α-glucosidase (EC 3.2.1.20), hippuric
acid, 2,2-diphenyl-1-picrylhydrazyl (DPPH), rabbit lung ACE (EC 3.4.15.1), cinnamic
acid, rosmarinic acid, protocatechuic acid, p-coumaric acid, chlorogenic acid, caffeic
acid, ferulic acid, and quercetin were purchased from Sigma Chemical Co. (St. Louis,
MO).

4.1.4.2 Sample Preparation

Water Extracts:
The samples (2.5 g) were extracted in 100 mL of distilled water under reflux at
95°C for 30 minutes. The samples were centrifuged for 10 minutes.

4.1.4.3 Total Soluble Phenolic Assay

The total phenolics in all samples were determined by using a method modified
by Shetty et al. (1995). In brief, 0.5 mL of sample extract was added to a test tube and
mixed with 0.5 mL of 95% ethanol and 5 mL of distilled water. To each sample, 0.5 mL
of 50% (vol/vol) Folin-Ciocalteu reagent was added and mixed. The absorbance was read
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at 725 nm using a spectrophotometer (Genesys UV/Visible, Milton Roy, Inc., Rochester,
NY). Different concentrations of gallic acid were used to develop a standard curve.
Results were expressed as mg of gallic acid/g of sample dry weight (DW).

4.1.4.4 Total Antioxidant Activity by DPPH Radical Inhibition Assay

The antioxidant activity was determined by the DPPH radical scavenging method
modified from Kwon et al. (2006). A 250 μL aliquot of the sample extract was mixed
with 1,250 μL of DPPH (60 μM in ethanol). The mixture was centrifuged at 13,000 g for
1 minute, and after this the absorbance was measured at 517 nm using the Genesys
UV/Visible spectrophotometer. The readings were compared with the controls,
containing 95% ethanol instead of sample extract. The percentage inhibition was
calculated by:

% inhibition =

( Absorbancecontrol − Absorbanceextract )
× 100
Absorbancecontrol

4.1.4.5 α-Amylase Inhibition Assay

The α-amylase inhibitory activity was determined by an assay modified from the
Worthington Enzyme Manual (Worthington, 1993). A total of 500 µL of sample extract
and 500 µL of 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M NaCl) containing
α-amylase solution (0.5 mg/mL) were incubated at 25°C for 10 minutes. After
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preincubation, 500 µL of a 1% starch solution in 0.02 M sodium phosphate buffer (pH
6.9 with 0.006 M NaCl) was added to each tube at timed intervals. The reaction was
stopped with 1.0 mL of dinitrosalicylic (DNS) acid color reagent. The test tubes were
incubated in a boiling water bath for 5 minutes and cooled to room temperature. The
reaction mixture was then diluted after adding 5-15 mL of distilled water, and the
absorbance was measured at 540 nm using the Genesys UV/Visible spectrophotometer.
The readings were compared with the controls, containing buffer instead of sample
extract. The percentage α-amylase inhibitory activity was calculated with the same
equation as for percentage inhibition in the DPPH radical inhibition assay.

4.1.4.6 α-Glucosidase Inhibition Assay

The α-glucosidase inhibitory activity was determined by an assay modified from
McCue et al. (2005). α-Glucosidase was assayed by using 50 μL of sample extracts and
100 μL of 0.1 M phosphate buffer (pH 6.9) containing α-glucosidase solution (1 U/mL)
and was incubated in 96-well plates at 25°C for 10 min. After preincubation, 50 μL of 5
mM p-nitrophenyl-α-d-glucopyranoside solution in 0.1 M phosphate buffer (pH 6.9) was
added to each well at timed intervals. The reaction mixtures were incubated at 25°C for 5
min. Before and after incubation, absorbance readings were recorded at 405 nm by a
microplate reader (Thermomax, Molecular Devices Co., Sunnyvale, CA) and compared
to a control that had 50 μL of buffer solution in place of the extract. The α-glucosidase
inhibitory activity was expressed as percentage inhibition and was calculated with the
same equation as for percentage inhibition in the DPPH radical inhibition assay. Dose
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dependency was tested using 25 µL and 10 µL of the sample, the volume made up to 50
µL using 0.1 M phosphate buffer (pH 6.9) and same protocol was followed.

4.1.4.7 ACE Inhibition Assay

ACE inhibition was assayed by a method modified by Kwon et al. (2006). The
substrate hippuryl-histidyl-leucine (HHL) and the enzyme ACE-I from rabbit lung (EC
3.4.15.1) were used. Fifty μL of sample extracts were incubated with 100 μL of 1 M
NaCl-borate buffer (pH 8.3) containing 2 mU of ACE-I solution at 37°C for 10 min.
After preincubation, 100 μL of a 5 mU substrate (HHL) solution was added to the
reaction mixture. Test solutions were incubated at 37°C for 1 hour. The reaction was
stopped with 150 μL of 0.5 N HCl. Five μL of the sample was injected in a highperformance liquid chromatography (HPLC) apparatus (Agilent 1100 series equipped
with autosampler and DAD 1100 diode array detector, Agilent Technologies, Palo Alto,
CA). The solvents used for gradient were (1) 10 mM phosphoric acid (pH 2.5) and (2)
100% methanol. The methanol concentration was increased to 60% for the first 8 min and
to 100% for 5 min and then was decreased to 0% for the next 5 min (total run time, 18
min). The analytical column used was an Agilent Nucleosil 100-5C18, 250 mm × 4.6 mm
inside diameter, with packing material of 5 μm particle size at a flow rate of 1 ml/min at
ambient temperature. During each run, the absorbance was recorded at 228 nm, and the
chromatogram was integrated using the Agilent Chemstation (Agilent Technologies)
enhanced integrator for detection of liberated hippuric acid (A). Hippuric acid standard
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was used to calibrate the standard curve and retention time. The percentage inhibition
was calculated by:

% inhibition =

(Acontrol − Aextract )
×100
(Acontrol − Ablank )

4.1.4.8 HPLC Analysis of Phenolic Phytochemicals

Two milliliters of the extracts was filtered (pore size, 0.2 μm), and 5 μL was
injected in the HPLC apparatus (Agilent 1100 series equipped with autosampler and
DAD 1100 diode array detector). The solvents used for gradient elution were (A) 10 mM
phosphoric acid (pH 2.5) and (B) 100% methanol. The methanol concentration was
increased to 60% for the first 8 minutes and to 100% over the next 7 minutes, then
decreased to 0% for the next 3 minutes, and maintained for the next 7 minutes (total run
time, 25 minutes). The analytical column used was an Agilent Zorbax SB-C18, 250 mm
× 4.6 mm i.d., with packing material of 5 μm particle size at a flow rate of 1 mL/minute
at ambient temperature. During each run the absorbance was recorded at 306 nm and 333
nm, and the chromatogram was integrated using the Agilent Chemstation enhanced
integrator. Calibration was performed by injecting the standards of cinnamic acid,
rosmarinic acid, protocatechuic acid, p-coumaric acid, chlorogenic acid, caffeic acid,
ferulic acid, and quercetin. Peak identification was performed by comparison of retention
times and diode array spectral characteristics with the standards. The results were
expressed as μg/g of sample DW.
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4.1.4.9 Statistical Analysis

All experiments were performed in either duplicates or triplicates. Analysis at
every time point from each experiment was carried out in duplicate or triplicate. Means,
standard errors and standard deviations were calculated from replicates within the
experiments and analyzed using Microsoft Excel XP.
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4.1.5

Results and Discussion

4.1.5.1 Total Soluble Phenolics and Antioxidant Activity

Potato has known to be domesticated in the Andes of Southern Peru about 10,000
years ago (Ames and Spooner, 2008). The type of potato grown in Chile (Solanum
tuberosum ssp. tuberosum L.) is known to be one of the highest yielding, along with
potatoes from the region of Argentina and Venezuela (Ames and Spooner, 2008). Not
many studies have been carried out to explore the health benefits of Chilean potato
(Solanum tuberosum ssp. tuberosum L.), in the context of its relevance for managing of
type II diabetes and hypertension through the diet. Although, it is known that the
consumption of potato with higher nutritional and bioactive profiles has the potential to
manage chronic diseases, its consumption in processed and fried forms such as French
fries and potato chips has raised health concerns. Such high fat processed forms
potentially increase risks for obesity-linked chronic diseases due to very high calorie
intake from higher than normal servings.
The amounts of total phenolic content between the 54 different Chilean potato
(Solanum tuberosum ssp. tuberosum L.) cultivars (varieties) were evaluated. The different
colors of potato samples indicated that, bright color potato samples potentially have
higher antioxidant and phenolics activity. Anthocyanins have been known to have
biological functions such as high antioxidant, antimicrobial and anti-obesity potential
(Zhang et al., 2009). It has been reported that, purple color of potato seems to be an
indication of anthocyanin presence, which is 3-4 times higher in the potato peel compared
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to tuber (Zhang et al., 2009). The variations ranged with high total phenolic content for
dark colors (purple, red and pink) and low phenolic content for light colors (white and
yellow) potatoes. Therefore we can assume that different peel colors of potato affects the
activity of antioxidants in a particular sample. The sample extraction method utilized was
the same for all 54 samples of Chilean potato (Solanum tuberosum ssp. tuberosum L.),
where 2.5 g of sample was extracted in 100 mL of water at 95°C for 30 minutes. Based
on these studies, enhancement and development of potato in accordance to increasing
their phenolic content would prove to be beneficial as a diet based management of
oxidation-linked chronic diseases such as type II diabetes.
Therefore, in this study, we focused on aqueous extracts of 54 different samples
of Chilean potato (Solanum tuberosum ssp. tuberosum L.), which were further evaluated
for hyperglycemia-linked anti-diabetic potentials and also for complications such as
hypertension using the appropriate in vitro assays as rapid screening tool. Figures 1, 2
and 3 illustrate the results for total phenolic content and total antioxidant activity of
aqueous extracts for all samples. The total phenolic content of Chilean potatoes ranged
from 0.92 mg/g (PA 43) to 13.1 (PA 4) mg/g of sample dry weight (DW). The total
phenolic content of all these samples showed a high correlation (r = 0.83) with
antioxidant activity by DPPH assay. Observing the sample colors indicated that high
phenolic and antioxidant activities were related with darker colors compared to low
activities linked to white and yellow varieties. In this study, many potato samples
consisted of high phenolic and antioxidant activity in aqueous extracts, which indicates
its potential for a good source of phenolic antioxidants.

40

The most important vitamin obtained from fruits and vegetables for human health
and nutrition is vitamin C. Potato is rich in vitamin C with the content of 15 mg/100 g of
steamed potato (Robert et al., 2006). The amount of vitamin C in a potato contributes to
25-30% of our recommended dietary allowance (Robert et al., 2006). The high amount of
overall antioxidants from both phenolics and vitamin C in potatoes can support our
bodies against oxidative complications linked to type II diabetes and cardiovascular
diseases, by limiting oxidative stress (Chu et al., 2002; Robert et al., 2006). Figures 1, 2
and 3 show the results for overall antioxidant activity by DPPH assay for 54 different
Chilean potato varieties. The in vitro antioxidant potential measured via DPPH inhibition
assay for potato samples ranged from 5.8% (PA 29) to 77% (PA 21). We can assume
that, Chilean potatoes with high antioxidant activity can be beneficial towards limiting
the oxidative stress and helping to manage the micro vascular oxidative stress-linked
complications of hyperglycemia and hypertension. High positive correlation was found
between total phenolics and antioxidant activity through DPPH assay for aqueous
extracts (r = 0.83).
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Figure 1 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total Antioxidant
Activity (% DPPH Inhibition ± Standard Error) correlation of Chilean Potatoes (Solanum
tuberosum ssp. tuberosum L.) for samples PA 1-18.
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Figure 2 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total Antioxidant
Activity (% DPPH Inhibition ± Standard Error) correlation of Chilean Potatoes (Solanum
tuberosum ssp. tuberosum L.) for samples PA 19-36.
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Figure 3 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total Antioxidant
Activity (% DPPH Inhibition ± Standard Error) correlation of Chilean Potatoes (Solanum
tuberosum ssp. tuberosum L.) for samples PA 38-54.

4.1.5.2 α–Glucosidase Inhibition Assay

In this study, we investigated health benefits of Chilean potato (Solanum
tuberosum ssp. tuberosum L.) for its hyperglycemic management potential linked to type
II diabetes. According to World Health Organization, 90% of people suffering from
diabetes mellitus around the world have type II diabetes (World Health Organization,
www.who.org). Type II diabetes is characterized through a constant increase in blood
glucose levels due to breakdown of starch foods by α- amylase and absorption of glucose
in small intestine by α–glucosidase (Ranilla et al., 2010). α–Glucosidase inhibitory
enzyme contributes in management of hyperglycemia, linked to type II diabetes (Pinto et
al., 2008; Shetty et al., 2010). Therefore early stages of type II diabetes could be
controlled via inhibition of α–glucosidase, which participates in the overall digestion and
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% DPPH Inhibition

90

DW)

Total Phenolics (mg GAE/ g

6

uptake of carbohydrates from the diet. Varieties that indicate high α–glucosidase
inhibitory activities can be further used in vivo studies as part of therapeutic or clinical
strategy, for managing hyperglycemia linked to type II diabetes.
Dose dependency (10 µL, 25µL, 50µL) of all samples evidently indicated dose
dependent response. Figures 4, 5 and 6 illustrate results of α–glucosidase inhibition for all
samples. The in vitro α–glucosidase inhibitory activity ranged from 0% (PA 17*, 35, 36,
38, 39, 40, 41, 52, 53, 54) to 59% (PA 13), and a large scale of variation was seen
between all 54 varieties of Chilean potato (Figure 4-6).
Extraction method for sample preparation was the same for α–glucosidase
inhibition assay, which is described above. Samples with no dilution (50 µL), indicated
the highest inhibition. Moderate correlation was observed between α–glucosidase
inhibition and total phenolic content for aqueous extracts of all samples (r = 0.50). Also,
a moderate correlation was seen between antioxidant activity through DPPH assay and α–
glucosidase inhibition (r = 0.54). We can therefore suggest that total phenolic content
and free radical-linked antioxidant activity is associated with α–glucosidase inhibitory
activity, since a moderately good correlation was observed. Also, these correlations may
suggest that the highest inhibition of α–glucosidase could be due to darker colors of
potato skins compared to lighter ones. Therefore, inhibitors in various skin samples of
Chilean potato can be utilized in therapeutic strategies to manage hyperglycemia. These
therapies and clinical strategies should be applied in early stages to manage
hyperglycemia for the prevention of type II diabetes.
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Figure 4 Changes observed in dose dependent (10 µL, 25 µL and 50 µL) percent αglucosidase inhibitory activity of Chilean Potatoes (Solanum tuberosum ssp. tuberosum
L.) for samples PA 1-18.

100
90
80

% Inhibition

70
60

1/5 Dilution

50

1/2 Dilution

40

No Dilution

30
20
10
0
PA PA PA PA PA PA PA PA PA PA PA PA PA PA PA PA PA PA
19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
Sample (Dilution)

Figure 5 Changes observed in dose dependent (10 µL, 25 µL and 50 µL) percent αglucosidase inhibitory activity of Chilean Potatoes (Solanum tuberosum ssp. tuberosum
L.) for samples PA 19-36.
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Figure 6 Changes observed in dose dependent (10 µL, 25 µL and 50 µL) percent αglucosidase inhibitory activity of Chilean Potatoes (Solanum tuberosum ssp. tuberosum
L.) for samples PA 38-54.

4.1.5.3 α- Amylase Inhibition Assay

α-Amylase is another enzyme similar to α–glucosidase, which is known to have
an important role in managing hyperglycemia linked to type II diabetes, though strong
inhibition could lead to undigested starch-linked side-effects (Kwon et al., 2006; Pinto et
al., 2009). In vitro α-amylase inhibition was evaluated for all 54 Chilean potato (Solanum
tuberosum ssp. tuberosum L.) varieties, with the same protocol for aqueous sample
preparation as rest of the inhibition assays described above. There was no α-amylase
inhibition observed for any of the samples (PA 1-54). It has been suggested that αamylase inhibitory activity could possibly be related to some specific phenolic
compounds (Pinto et al., 2009), which might not be present in samples observed in this
study. Though α-amylase inhibitory activity is low the benefits of α–glucosidase
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inhibition is reasonable for select varieties to be considered as a component of a whole
food design that can be part of our diet to help manage hyperglycemia linked to type II
diabetes in its early stages (Pinto et al., 2009; Shetty et al., 2010).

4.1.5.4 ACE Inhibition Assay

Cardiovascular diseases (CVD) are known to be one of the leading causes of
deaths worldwide. Diets rich in fruits and vegetables are recommended for prevention of
CVD, and its consumption lowers the risk of CVD including hypertension, which is a
macro vascular complication of type II diabetes (Bazzano et al., 2003; Kwon et al.,
2006). Fruits and vegetables include combinations of micronutrients, antioxidants,
phytochemicals and fibers which may be able to reduce the risk of cardiovascular
diseases (Liu et al., 2000). ACE inhibition is an important target for hypertension
management, and in this study we have evaluated inhibition of this particular enzyme in
response to aqueous potato extracts. The evaluation of 54 different varieties of Chilean
potato (Solanum tuberosum ssp. tuberosum L.) with varying colors, would also give us an
idea of how important total phenolic content is in the context of anti-hypertensive
potentials of a specific varieties.
Figure 7, 8 and 9 shows ACE inhibitory activity for aqueous extracts of all potato
samples. The in vitro ACE inhibitory activity ranged from 0% (PA 2, 9, 14, 15, 20, 2227, 29-31, 33, 40, 48-51) to as high as 88% (PA 17). ACE inhibitory activity showed
high variance for its inhibitions. Low correlation was observed between total phenolics
and ACE inhibition (r = 0.13). Also, a low correlation was observed between antioxidant
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activity by DPPH assay and ACE inhibition (r = 0.21). Correlations observed in this
study suggest that ACE inhibitory activity does not depend on specific phenolic
compounds present in potato samples. .Same observation can be true for antioxidant
activity, because the correlation does not show relevant activity between aqueous extracts
of DPPH assay and ACE inhibition. Specific phenolic compounds found in potato may be
able to reduce the risk of hypertension, type II diabetes and other various conditions for
cardiovascular diseases. It is also possible that bioactive components other than phenolics
may be responsible for ACE inhibitory activity (Kwon et al., 2006; Pinto et al., 2009).

100
90
80
% Inhibition

70
60
50
40
30
20
10
0
PA 1 PA 2 PA 3 PA 4 PA 5 PA 6 PA 7 PA 8 PA 9 PA
10

PA
11

PA
12

PA
13

PA
14

PS
15

PS
16

PA
17

PA
17*

PA
18

Sample

Figure 7 ACE inhibitory activity (% Inhibition) of Chilean Potatoes (Solanum tuberosum
ssp. tuberosum L.) for samples PA 1-18.
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Figure 8 ACE inhibitory activity (% Inhibition) of Chilean Potatoes (Solanum tuberosum
ssp. tuberosum L.) for samples PA 19-36.
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Figure 9 ACE inhibitory activity (% Inhibition) of Chilean Potatoes (Solanum tuberosum
ssp. tuberosum L.) for samples PA 38-54.
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4.1.5.5 HPLC Analysis of Phenolic Phytochemicals

Regular intake of natural phenolic compounds through our diet has beneficial
affects on our overall health through potential reduction of oxidation-linked chronic
diseases. Aqueous extracts of all samples were analyzed for phenolic profile via HPLC.
Table 1, 2 and 3 includes data for different compounds found in potatoes. The peaks were
identified based on retention time and ultraviolet absorption spectra of corresponding
standards (Pinto et al., 2009). The five phenolic compounds found in the samples
included chlorogenic acid, ferulic acid, caffeic acid, p-coumaric acid and catechin.
Chlorogenic acid is known to contain about 90% of total phenolic compounds of
potato tubers (Dao and Friedman, 1992), and might play an important role in quality and
safety of potato plant. Phenolic profile analysis of chlorogenic acid ranged from absence
(PA 27, 30, 34, 39, 41*, 48) to 17.9 mg/g (PA 8) of sample DW. Chlorogenic acid has the
ability to lower blood pressure in mildly hypertensive patients, and its derivatives have
shown to lower blood pressure in hypertensive rats (Cheplick et al., 2010). The phenolic
compound ferulic acid analyzed in potatoes ranged from absence in some samples (PA
27, 29, 30, 31, 36, 39, 40, 43, 48, and 52) to 10.5 mg/g (PA 21) of sample DW. Ferulic
acid has a potential via natural sources to prevent cardiovascular disease and diabetes
(Zhao et al., 2008). Potato along with eggplant and tomato are good sources of ferulic
acid, which are shown to supply anywhere from 5-70 mg of ferulic acid/ 100 g (Zhao et
al., 2008). Caffeic acid was observed to be absent (PA 1, 3, 11, 17*, 36, 51 and 54) to
10.3 mg/g (PA 42) of sample DW. Caffeic acid has been observed to have beneficial
potential for managing cardiovascular diseases, as well as its hypotensive affects in
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hypertensive rats (Li et al., 2005). Another phenolic compound observed in potato
samples included p-coumaric acid, which ranged from absent (PA 15, 24-33, 36, 40, 45,
48 and 54) to 7.3 mg/g (PA 21) of sample DW. The last phenolic compound observed
was catechin, which ranged from absence 10, 15, 18, 22) to 4.35 mg/g (PA 54) of sample
DW. Matsui et al. (2007) has suggested that catechin has the potential to prevent diabetes
through natural intake in our diet. Catechins have heart diseases and cancer prevention
potential, but another study (Nagao et al., 2007) was carried out to observe its fat
reducing abilities. Continuous consumption of catechins via our diet, especially in high
amounts, indicated reduction of fat, cholesterol levels and blood pressure without drastic
changes in our lifestyles (Nagoa et al., 2007). Therefore, we can assume that inclusion of
the right sub-tropical cultivars of Chilean potato could be potentially beneficial towards
our health with potential for prevention of hyperglycemia and hypertension in early
stages of type II diabetes and associated cardiovascular diseases in the long term.
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Table 1 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Chilean
Potato (Solanum tuberosum ssp. tuberosum L.): Samples 1-18.
Chlorogenic
Acid

Ferulic Acid

Caffeic Acid

P-Coumaric Acid

Catechin

mg/g DW

mg/g DW

mg/g DW

mg/g DW

mg/g DW

PA 1

13.9 ± 2.99

0.23 ± .003

3.08 ± 0.17

3.08 ± 2.17

PA 2

14.9 ± 3.72

4.32 ± 0.51

0.13 ± .003

0.13 ± 0.09

PA 3

11.7 ± 3.36

1.18 ± 0.31

1.05 ± 0.40

0.62 ± 0.44

PA 4

16.5 ± 6.38

1.79 ± 0.39

2.58 ± 0.02

2.16 ± 0.32

1.61 ± 1.14

PA 5

15.9 ± 4.42

2.27 ± 0.26

1.59 ± 0.05

0.57 ± 0.22

0.96 ± 0.68

PA 6

13.3 ± 4.17

1.35 ± 0.39

1.12 ± 0.02

0.50 ± 0.10

0.64 ± 0.45

PA 7

16.2 ± 4.98

0.82 ± 0.27

0.94 ± 0.03

1.87 ± 0.59

1.21 ± 0.85

PA 8

17.9 ± 5.59

2.20 ± 1.14

0.35 ± .004

1.19 ± 0.54

0.21 ± 0.10

PA 9

3.50 ± 0.72

1.51 ± 0.50

0.20 ± 0.04

0.12 ± .001

2.49 ± 1.76

PA 10

2.39 ± 1.16

1.09 ± 0.57

1.85 ± 0.49

1.36 ± .001

PA 11

19.3 ± 5.12

6.27 ± .006

PA 12

15.6 ± 4.29

1.30 ± 0.30

PA 13

15.5 ± 2.76

PA 14

SAMPLE

6.77 ± 2.73

2.23 ± 0.87

0.71 ± 0.50

1.34 ± 0.12

1.19 ± 0.18

0.89 ± 0.63

4.26 ± 1.42

3.24 ± 0.01

1.82 ± 0.60

0.77 ± 0.55

8.92 ± 2.26

1.81 ± 0.62

1.15 ± 0.20

2.22 ± 0.44

1.44 ± 1.02

PA 15

4.82 ± 1.33

0.47 ± 0.16

0.83 ± .001

PA 16

6.86 ± 1.93

1.44 ± 0.26

0.60 ± .001

0.55 ± .007

0.74 ± 0.53

PA 17

5.95 ± 1.60

1.11 ± 0.36

0.92 ± 0.21

1.40 ± 0.26

0.94 ± 0.66

PA 17*

6.36 ± 1.39

0.53 ± 0.19

1.37 ± 0.41

1.56 ± 0.78

PA 18

13.3 ± 2.11

2.28 ± 0.69

1.33 ± 0.46
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4.66 ± 0.06

Table 2 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Chilean Potato
(Solanum tuberosum ssp. tuberosum L.): Samples 19-36.
Chlorogenic
Acid

Ferulic Acid

Caffeic Acid

P-Coumaric
Acid

Catechin

mg/g DW

mg/g DW

mg/g DW

mg/g DW

mg/g DW

PA 19

6.44 ± 2.51

2.08 ± 0.45

0.91 ± 0.07

1.58 ± 0.41

0.22 ± 0.07

PA 20

7.23 ± 2.60

1.05 ± 0.38

0.15 ± 0.07

0.36 ± 0.27

0.22 ± 0.08

PA 21

0.15 ± 0.00

10.5 ± 1.34

3.99 ± 0.74

7.31 ± 2.66

0.43 ± .006

PA 22

19.6 ± 7.68

3.39 ± 0.19

0.72 ± .004

3.06 ± 1.13

PA 23

2.11 ± 0.24

0.05 ± 0.01

1.54 ± 0.55

0.14 ± 0.05

PA 24

1.99 ± .002

0.10 ± 0.02

0.86 ± 0.25

0.22 ± 0.09

PA 25

6.42 ± 2.26

0.71 ± 0.27

1.53 ± 0.54

0.53 ± 0.13

PA 26

0.09 ± .001

0.15 ± .001

0.16 ± .002

0.54 ± 0.12

0.10 ± 0.01

0.60 ± 0.12

0.49 ± .003

1.06 ± 0.14

0.06 ± 0.00

0.80 ± 0.27

0.81 ± 0.19

0.16 ± 0.05

0.19 ± 0.02

1.92 ± 0.57

SAMPLE

PA 27
PA 28

0.21 ± 0.05

PA 29

0.16 ± .001

0.03 ± .002

PA 30

0.11 ± 0.04

PA 31

0.07 ± .005

PA 32

0.44 ± 0.02

0.16 ± 0.07

2.54 ± 0.03

0.64 ± 0.11

PA 33

1.53 ± 0.41

0.33 ± 0.07

3.02 ± 0.25

1.71 ± 0.04

0.15 ± 0.06

3.28 ± 0.68

0.18 ± 0.03

2.17 ± 0.16

0.18 ± .005

0.51 ± .006

0.07 ± .007

1.05 ± 0.03

PA 34
PA 35

0.47 ± 0.06

PA 36

3.00 ± 0.54

0.42 ± .002
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Table 3 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Chilean Potato
(Solanum tuberosum ssp. tuberosum L.): Samples 38-54.
SAMPLE

PA 38

Chlorogenic Acid

Ferulic Acid

Caffeic Acid

P-Coumaric
Acid

Catechin

mg/g DW

mg/g DW

mg/g DW

mg/g DW

mg/g DW

1.54 ± 0.49

0.47 ± 0.04

0.95 ± 0.29

0.13 ± .002

0.34 ± 0.18

0.07 ± 0.01

0.04 ± .005

1.03 ± 0.16

PA 39
PA 40

1.94 ± 0.01

PA 41

3.22 ± 0.06

PA 41*

0.88 ± 0.23

1.45 ± 0.36

0.03 ± 0.00

2.07 ± .009

0.05 ± 0.01

1.31 ± 0.45

0.29 ± 0.11

3.28 ± 0.51

0.04 ± 0.10

1.62 ± 0.48

0.86 ± 0.22

10.3 ± 0.11

1.00 ± 0.25

2.73 ± 0.11

0.41 ± 0.08

0.03 ± .001

0.87 ± 0.26

0.66 ± 0.06

2.31 ± 0.20

PA 42

4.76 ± 1.72

PA 43

1.41 ± 0.48

PA 44

1.14 ± 0.29

0.04 ± .007

0.86 ± 0.24

PA 45

0.25 ± .003

0.09 ± 0.02

0.80 ± 0.19

PA 46

1.33 ± 0.27

0.14 ± 0.06

4.04 ± 0.83

0.68 ± 0.11

1.55 ± 0.16

PA 47

0.28 ± .002

0.06 ± 0.01

0.28 ± 0.04

0.13 ± 0.02

1.32 ± 0.16

PA 48

1.04 ± 0.24

0.14 ± .006

PA 50

2.46 ± 0.01

0.08 ± .006

PA 51

0.61 ± 0.08

0.04 ± .003

PA 52

1.01 ± 0.53

PA 53

0.98 ± .002

0.07 ± .007

PA 54

0.53 ± 0.03

0.03 ± .001

2.33 ± 1.06

2.26 ± 0.97
0.17 ± .002

1.33 ± 0.13

0.05 ± .002

4.15 ± 0.84

1.58 ± .022

0.03 ± .001

0.98 ± 0.46

0.46 ± 0.02

0.05 ± .005

2.64 ± 0.57
4.35 ± 0.72
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4.1.6

Conclusions

In this study, we have evaluated anti-diabetic and anti-hypertensive management
potential of Chilean Potatoes (Solanum tuberosum ssp. tuberosum L.) linked to type II
diabetes using in vitro models. We utilized the usual preparation method of potato
through hot water extraction. Total soluble phenolics, total antioxidant activity by DPPH
inhibition and functionality assays such as α-glucosidase inhibition, α-amylase inhibition
and ACE inhibition were also evaluated. The results of this study indicated that Chilean
potatoes do not have α-amylase inhibitory potential. However, the. α-glucosidase
inhibition observed show a large variation between all 54 samples. The inhibition ranged
upto 60%, which indicates that some potato varieties could be considered part of our diet
to prevent hyperglycemia linked to type II diabetes. Some potato varieties observed
showed a high ACE inhibition activity, which indicated that specific varieties could be
potentially beneficial towards prevention of hypertension. This study provides important
information on functions of several Chilean potato varieties, so appropriate varieties
could be part of breeding programs and food designs to be part of diets to prevent
hyperglycemia and hypertension linked to type II diabetes. Based on wide screening
using in vitro assays and a strong biochemical rationale, specific varieties could be part of
diet designs for animal and clinical studies.
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4.2
Anti-diabetic Potential and Seed Phytochemicals of Select Species of Family
Apiaceae Using In Vitro Assays
4.2.1

Abstract

A global epidemic of type II diabetes worsens food-based therapeutic strategies
for the prevention and management is being explored. Water and 12% ethanol extracts of
seeds of six select species of family Apiaceae were evaluated for total soluble phenolic
assay and DPPH inhibition assay. In vitro assays such as α-glucosidase and α-amylase
inhibition for anti-hyperglycemia potential and angiotensin I-converting enzyme (ACE)
inhibition for anti-hypertension potential relevant to type II diabetes management were
evaluated. Total phenolic content for aqueous extracts ranged from 4.8 mg/g (Coriander)
to 8.3 mg/g (Ajowan) of DW. Total phenolic content and antioxidant activity for aqueous
extracts indicated a moderate correlation (r = 0.61), and a high correlation (r = 0.73) for
ethanolic extracts. α-Glucosidase inhibitory activity for aqueous extracts ranged from
16.5% (Caraway) to 50% (Dill). These in vitro assays indicate that select family
Apiaceae species used as food condiments have anti-diabetic potentials. This provides the
biochemical basis for therapeutic strategies for including these condiments as part of
improved diet for prevention of hyperglycemia and associated hypertension.
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4.2.2

Industrial Relevance

Utilizing plant sources as medicinal food has been widely used throughout the
world since ancient times. Developing strategies to explore efficacy of plant sources
towards prevention of hyperglycemia and hypertension linked to type II diabetes would
serve as the basis for innovation towards industrial applications. This study investigates
functionalities of seed extracts of select species from family Apiaceae with potential for
therapeutic and medicinal uses for prevention of hyperglycemia and hypertension linked
to type II diabetes. This strategy has low toxicity compared to synthetic drugs. Also,
availability of plant sources in localized communities based on local bioresources for
disease management is potentially easier and less expensive than synthetic medicines.
Therefore understanding functionalities of seed sources of family Apiaceae would lead to
dietary strategies for hyperglycemia and hypertension management, which would be
available as condiments at a low cost to wider communities globally.
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4.2.3

Introduction

Type II diabetes results from the inability of our body’s to response to high blood
glucose levels from high carbohydrate diets leading to several metabolic and pathological
changes. Type II diabetes is one of the most common diseases affecting the people of
both developed and developing countries, affecting about 5%-7% of the population in
several countries. The number of people suffering from type II diabetes is believed to be
rising constantly worldwide and is projected to increase to 400 million by 2030. Plantbased medicinal drugs have been used for various disease therapies since ancient times.
Even though there has been a considerable progress in managing type II diabetes through
synthetic drugs, investigation for natural anti-diabetic plant and food products for its
management has potential to offer effective less expensive strategies. In addition
hypoglycemic activities of many plant species have been discovered, acting as antimetabolites to help block the oxidation pathway of fatty acids (Ahmad et al., 2009).
Plants from family Apiaceae are commonly used as food, flavoring of foods and
for their medicinal purposes. Seeds from family Apiaceae have been used as a common
household remedy for many complications such as hypertension (Gilani et al., 2005).
Plants from Apiaceae family are used in Rajasthan, India to treat common ailments such
as stomachaches, abdominal pain and acidity (Shekhawat and Batra, 2006). Mixture of
different plants is consumed orally with water or applied externally through massaging
abdomen with it (Shekhawat and Batra, 2006). In parts of the world such as Cameroon,
plants from Apiaceae family are used as therapies for vomiting, appendicitis, ingestion,
constipation and treating mosquito bites (Jiofack et al., 2009).
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Ancient form of Indian medicine ‘Ayurveda’ uses the active ingredients from
plants for treatment of various diseases (Dhandapani et al., 2002). Compared to synthetic
drugs, plant products are less toxic and have less of side effects. Plants from Apiaceae
family are frequently considered to have hypoglycemic affects on humans and animals
(Dhandapani et al., 2002). Hypoglycemic action of plants are due to insulin effect by
increasing pancreatic secretion of insulin from cells of islets of Langerhan’s or its release
from bound insulin (Dhandapani et al., 2002).
Additionally other seed extracts from Apiaceae family have been observed for
their health beneficial effects. Essential oils from Foeniculum vulgare seeds (Fennel)
such as anethole and limonene are used for medicinal purposes and their seeds are also
used as tranquillizers and tonics (Oktay et al., 2003). Aqueous extracts of fennel are
observed for its hypotensive effect in a dose-related manner (Oktay et al., 2003).
Anethum graveolens seed (Dill) extracts are used to treat diarrhea and scours as well as
feeding it to goats and cows for enhancing milk production (Lans et al., 2007).
Coriandrum sativum seeds (Coriander) are mainly used as food flavoring agent and also
used to treat ulcers (Husain et al., 2008). Trachyspermum copticum (Ajowan) seeds are
frequently used to treat diarrhea, ingestion and common colds. Ajowan seed oils are
suggested to treat medical problems affecting joints or painful muscle conditions (Husain
et al., 2008). Carum carvi (Caraway) is suggested to have beneficial effects for treatment
and management of diabetes and cardiovascular diseases. It evokes beneficial effects on
the elevation of lipids in the bloodstream associated with hyperglycemia (Lemhadri et al.,
2006). Pimpinella anisum (Anise) is a plant belonging to Apiaceae family native to the
Middle East which is used as aromatic spice and to help digestion (Arslan et al., 2004).
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Understanding the biochemical basis for medicinal uses and phytotherapies of
Apiaceae family with a focus on their seeds would provide us with a basis for further
clinical research which will provide insight on how they could be targeted towards
prevention of certain chronic diseases. Plant-based medicinal treatments for targeted
prevention of diabetes and other diseases are going to play an important part due to its
low toxicity potentials and low cost for wide usage. In this study, we have investigated
functionalities of seeds of 6 select species of family Apiaceae, and how their in vitro
effects could provide a biochemical rationale to potentially target them towards the
prevention and management of hyperglycemia and hypertension linked to type II
diabetes. We evaluated total soluble phenolics and DPPH inhibition assay to determine
total antioxidant activity and used High Performance Liquid Chromatography for analysis
of phenolic phytochemicals of seeds. In vitro assays such as α-glucosidase, α-amylase
and angiotensin converting enzyme (ACE) inhibitory activities were performed to
evaluate seeds potential towards hyperglycemia and hypertension management as part of
dietary strategies for management of type II diabetes and its complications.
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4.2.4

Materials and Methods

4.2.4.1 Materials

Apiaceae family seeds were Swad brand dill, ajowan, fennel, coriander and anise
were purchased from a local Asian grocery store (Asian-American International) in
Hadley, MA, USA. Caraway sample evaluated was purchased from Whole Foods Market
Hadley, MA, USA. Porcine pancreatic α-amylase (EC 3.2.1.1), rat intestinal αglucosidase (EC 3.2.1.20), hippuric acid, 2,2-diphenyl-1-picrylhydrazyl (DPPH), rabbit
lung ACE (EC 3.4.15.1), cinnamic acid, rosmarinic acid, protocatechuic acid, p-coumaric
acid, chlorogenic acid, caffeic acid, ferulic acid, and quercetin were purchased from
Sigma Chemical Co. (St. Louis, MO).

4.2.4.2 Sample Preparation

Water Extracts:
The samples (2.5 g) were extracted in 100 mL of distilled water under reflux at
95°C for 30 minutes. The samples were centrifuged for 10 minutes.

Ethanol extracts:
The samples (2.5 g) were extracted in 100 mL of 12% ethanol in a shaker at a
speed of 150 RPM overnight at 20°C. The samples were filtered and stored in a
refrigerator at –20°C until analysis, for no more than 1 week.
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4.2.4.3 Total Soluble Phenolic Assay

The total phenolics in all samples were determined by using a method modified
by Shetty et al. (1995). In brief; 0.5 ml of sample extract was added to a test tube and
mixed with 0.5 mL of 95% ethanol and 5 mL of distilled water. To each sample, 0.5 mL
of 50% (vol/vol) Folin-Ciocalteu reagent was added and mixed. The absorbance was read
at 725 nm using a spectrophotometer (Genesys UV/Visible, Milton Roy, Inc., Rochester,
NY). Different concentrations of gallic acid were used to develop a standard curve.
Results were expressed as mg of gallic acid/g of sample dry weight (DW).

4.2.4.4 Total Antioxidant activity by DPPH Radical Inhibition Assay

The antioxidant activity was determined by the DPPH radical scavenging method
modified from Kwon et al. (2006). A 250-μL aliquot of the sample extract was mixed
with 1,250 μL of DPPH (60 μM in ethanol). The mixture was centrifuged at 13,000 g for
1 minute, and after this the absorbance was measured at 517 nm using the Genesys
UV/Visible spectrophotometer. The readings were compared with the controls,
containing 95% ethanol instead of sample extract. The percentage inhibition was
calculated by:

% inhibition =

(Absorbancecontrol − Absorbanceextract )
×100
Absorbancecontrol
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4.2.4.5 α-Amylase Inhibition Assay

The α-amylase inhibitory activity was determined by an assay modified from the
Worthington Enzyme Manual (Worthington, 1993). A total of 500 µL of sample extract
and 500 µL of 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M NaCl) containing
α-amylase solution (0.5 mg/mL) were incubated at 25°C for 10 minutes. After
preincubation, 500 µL of a 1% starch solution in 0.02 M sodium phosphate buffer (pH
6.9 with 0.006 M NaCl) was added to each tube at timed intervals. The reaction was
stopped with 1.0 mL of dinitrosalicylic acid color reagent. The test tubes were incubated
in a boiling water bath for 5 minutes and cooled to room temperature. The reaction
mixture was then diluted after adding 5-15 mL of distilled water, and the absorbance was
measured at 540 nm using the Genesys UV/Visible spectrophotometer. The readings
were compared with the controls, containing buffer instead of sample extract. The
percentage α-amylase inhibitory activity was calculated with the same equation as for
percentage inhibition in the DPPH radical inhibition assay.

4.2.4.6 α-Glucosidase Inhibition Assay

The α-glucosidase inhibitory activity was determined by an assay modified
from McCue et al. (2005). α-Glucosidase was assayed by using 50 μL of sample extracts
and 100 μL of 0.1 M phosphate buffer (pH 6.9) containing α-glucosidase solution (1
U/mL) and was incubated in 96-well plates at 25°C for 10 min. After preincubation, 50
μL of 5 mM p-nitrophenyl-α-d-glucopyranoside solution in 0.1 M phosphate buffer (pH
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6.9) was added to each well at timed intervals. The reaction mixtures were incubated at
25°C for 5 min. Before and after incubation, absorbance readings were recorded at 405
nm by a microplate reader (Thermomax, Molecular Devices Co., Sunnyvale, CA) and
compared to a control that had 50 μL of buffer solution in place of the extract. The αglucosidase inhibitory activity was expressed as percentage inhibition and was calculated
with the same equation as for percentage inhibition in the DPPH radical inhibition assay.
Dose dependency was tested using 25 µl and 10 µl of the sample, the volume made up to
50 µl using 0.1 M phosphate buffer (pH 6.9) and same protocol was followed.

4.2.4.7 ACE Inhibition Assay

ACE inhibition was assayed by a method modified by Kwon et al. (2006). The
substrate hippuryl-histidyl-leucine (HHL) and the enzyme ACE-I from rabbit lung (EC
3.4.15.1) were used. Fifty μL of sample extracts were incubated with 100 μL of 1 M
NaCl-borate buffer (pH 8.3) containing 2 mU of ACE-I solution at 37°C for 10 min.
After preincubation, 100 μL of a 5 mU substrate (HHL) solution was added to the
reaction mixture. Test solutions were incubated at 37°C for 1 hour. The reaction was
stopped with 150 μL of 0.5 N HCl. Five μL of the sample was injected in a highperformance liquid chromatography (HPLC) apparatus (Agilent 1100 series equipped
with autosampler and DAD 1100 diode array detector, Agilent Technologies, Palo Alto,
CA). The solvents used for gradient were (1) 10 mM phosphoric acid (pH 2.5) and (2)
100% methanol. The methanol concentration was increased to 60% for the first 8 min and
to 100% for 5 min and then was decreased to 0% for the next 5 min (total run time, 18
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min). The analytical column used was an Agilent Nucleosil 100-5C18, 250 mm × 4.6 mm
inside diameter, with packing material of 5 μm particle size at a flow rate of 1 mL/min at
ambient temperature. During each run, the absorbance was recorded at 228 nm, and the
chromatogram was integrated using the Agilent Chemstation (Agilent Technologies)
enhanced integrator for detection of liberated hippuric acid (A). Hippuric acid standard
was used to calibrate the standard curve and retention time. The percentage inhibition
was calculated by:

% inhibition =

(Acontrol − Aextract )
×100
(Acontrol − Ablank )

4.2.4.8 HPLC Analysis of Phenolic Phytochemicals

Two milliliters of the extracts was filtered (pore size, 0.2 μm), and 5 μL was
injected in the HPLC apparatus (Agilent 1100 series equipped with autosampler and
DAD 1100 diode array detector). The solvents used for gradient elution were (A) 10 mM
phosphoric acid (pH 2.5) and (B) 100% methanol. The methanol concentration was
increased to 60% for the first 8 minutes and to 100% over the next 7 minutes, then
decreased to 0% for the next 3 minutes, and maintained for the next 7 minutes (total run
time, 25 minutes). The analytical column used was an Agilent Zorbax SB-C18, 250 mm
× 4.6 mm i.d., with packing material of 5 μm particle size at a flow rate of 1 mL/minute
at ambient temperature. During each run the absorbance was recorded at 306 nm and 333
nm, and the chromatogram was integrated using the Agilent Chemstation enhanced
integrator. Calibration was performed by injecting the standards of cinnamic acid,
rosmarinic acid, protocatechuic acid, p-coumaric acid, chlorogenic acid, caffeic acid,
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ferulic acid, and quercetin. Peak identification was performed by comparison of retention
times and diode array spectral characteristics with the standards. The results were
expressed as μg/g of sample DW.

4.2.4.9 Statistical Analysis

All experiments were performed in either duplicates or triplicates. Analysis at
every time point from each experiment was carried out in duplicate or triplicate. Means,
standard errors and standard deviations were calculated from replicates within the
experiments and analyzed using Microsoft Excel XP.
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4.2.5

Results and Discussion

4.2.5.1 Total Soluble Phenolics and Total Antioxidant Activity by DPPH

In this study, we focused on aqueous and ethanolic extracts from seeds of six
different species from the family Apiaceae, to screen their anti-hyperglycemia and antihypertension potentials using in vitro assays. Figure 10 shows the total phenolic content
of aqueous seed extracts. Total phenolic content for these samples ranged from 4.8 mg/g
(Coriander) to 8.3 mg/g (Ajowan) of sample DW. Figure 11 shows total phenolic content
of ethanolic extracts, which ranged from 2.42 mg/g (Caraway) to 8 mg/g (Ajowan) of
sample DW. Plant phenolic content is known to be linked to therapeutic potential for use
in prevention and management of type II diabetes. Medicinal plant species observed in
this study could be considered a good source of polyphenols due to their high total
phenolic content (Kesilova et al., 2006), and related total antioxidant activity. The
moderate and high correlations in this study suggest that, high antioxidant potential
varied for each species.
Figure 10 shows results for antioxidant activity by DPPH assay for aqueous
extracts. In vitro antioxidant activity measured by DPPH assay for aqueous extracts
ranged from 62.8% (Caraway) to 76.5% (Dill). Total phenolic content of aqueous
samples indicated a moderate correlation (r = 0.61) with antioxidant activity by DPPH
assay. Addition of antioxidants to the diet has potential for slowing down oxidation of
fats (Yen and Duh, 1994), and can be identified as free radical or active oxygen
scavengers (Oktay el al., 2003). Therefore, high DPPH inhibition observed for aqueous
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extracts suggest that inclusion of these seed ingredients from food condiment sources in
our diet could have relevance for combating chronic oxidation-linked metabolic pathways
associated with high calorie diet and associated obesity. This could potentially serve as an
important factor for controlling obesity which is linked to the incidence of type II
diabetes.
Figure 11 shows the results of ethanolic extracts for all samples, which ranged
from 25.1% (Coriander) to 68.7% (Ajowan). Total phenolic content of ethanolic extracts
had a high correlation (r = 0.73) with antioxidant activity by DPPH.

This high

correlation suggests that the amount of antioxidants in ethanolic extracts is due to the
phenolic content of plant species as suggested by Kesilova et al. (2006) and many other
studies. Specific species with high antioxidant activity from family Apiaceae such as dill
and ajowan could be part of food preparation as condiments in foods for managing
chronic disease states or even as medicinal material for replacing synthetic antioxidants.
Synthetic antioxidants are also being restricted due to their carcinogenicity (Zheng and
Wang, 2001), and natural antioxidants have the capability of both preserving food,
adding flavor and potentially protecting human body from free radicals and associated
chronic diseases (Oktay et al., 2003).
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Figure 10 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total
Antioxidant Activity (% DPPH Inhibition ± Standard Error) correlation of aqueous
extracts of Dill, Ajowan, Fennel, Caraway, Coriander and Anise.
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Figure 11 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total
Antioxidant Activity (% DPPH Inhibition ± Standard Error) correlation of ethanolic
extracts of Dill, Ajowan, Fennel, Caraway, Coriander and Anise.
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% DPPH Inhibition

Total Soluble Phenolics (mg
GAE/ g DW)
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4.2.5.2 α-Glucosidase Inhibition

Dose dependency studies (10µL, 25µL, 50µL) for the 6 species of family
Apiaceae demonstrated dose dependent responses. Figure 12 illustrates the results for
aqueous extracts, which ranged from 0% inhibition (Coriander and Anise) to almost 50%
inhibition (Dill). The total phenolic content for aqueous extracts showed a high
correlation (r = 0.86) with α-glucosidase inhibition. Also, the total phenolic content for
ethanolic extracts showed a high correlation (r = 0.76) with α-glucosidase inhibition.
Natural herbal medicines have been targeted all over the world for prevention of high
blood pressure and type II diabetes (Loizzo et al., 2008). α-Glucosidase inhibition results
from this study suggest that family Apiaceae consists of certain hypoglycemic bioactive
compounds. This inhibition of digestive enzyme α-glucosidase would delay the
degradation of oligosaccharides, which would decrease the absorption of glucose
inhibiting the increase in postprandial hyperglycemia (Loizzo et al., 2008). High
antioxidant activity and total phenolic content appeared to be a good predictor of αglucosidase inhibition because of its high correlation for aqueous extracts. Therefore
condiments with high α-glucosidase inhibition such as Dill and Ajowan could be used as
condiment target species from family Apiaceae to be part of dietary management of
hyperglycemia linked to type II diabetes.
Figure 13 shows the results of α-glucosidase inhibition for ethanolic extracts.
Unlike aqueous extracts, where samples Coriander and Anise showed no inhibition, for
ethanolic extracts there was some inhibition for all 6 samples. α-Glucosidase inhibition
for ethanolic extracts ranged from 1.7% (Anise) to 32% (Ajowan). Antioxidant activity
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for aqueous extracts showed a low correlation (r = 0.48) with α-glucosidase inhibition. In
terms of antioxidant activity ethanolic extracts showed a moderate correlation (r = 0.55)
with α-glucosidase inhibition. Overall, α-glucosidase inhibition observed for ethanolic
extracts is lower than aqueous extracts, but suggests that they still contain hypoglycemic
bioactive compounds required for potentially managing hyperglycemia. We suspect that
higher inhibition of aqueous extracts could be a more natural way of preparing food, and
preparation with hot water might be more efficient for the outcome to naturally reach
digestive enzymes to manage hyperglycemia. Based on these results, seed sources of
plant species such as family Apiaceae has the potential for anti-diabetic activity which
could prove to be effective as the clinical agents when consumed in small doses on a
consistent basis through the diet. Overall high antioxidant activity and total phenolic
content did not prove to be a good indicator of α-glucosidase inhibition because of low to
moderate correlations for both aqueous and ethanol extracts.
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Figure 12 Changes observed in dose dependent (10 µL, 25 µL, 50 µL) % α-glucosidase
inhibitory activities for aqueous extracts of Dill, Ajowan, Fennel, Caraway, Coriander
and Anise.
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Figure 13 Changes observed in dose dependent (10 µL, 25 µL, 50 µL) % α-glucosidase
inhibitory activities for ethanolic extracts of Dill, Ajowan, Fennel, Caraway, Coriander
and Anise.

4.2.5.3 α- Amylase Inhibition

Dose dependency studies (10µl, 25µ1, 50µl) allowed us to observe dose
dependent responses for the 6 species of family Apiaceae. Figure 14 shows results for
aqueous extracts, which were in the range from 0% (Ajowan) to 32% (Caraway). Total
phenolic content for aqueous extracts demonstrated an inverse correlation (r = -0.54)
with α-amylase inhibition. Also, phenolic content for ethanolic extracts showed an
inverse correlation (r = -0.66) with α- amylase inhibition. Above correlations observed,
indicated that total phenolic content has no influence on α-amylase inhibition. Previous
studies have suggested that α-amylase inhibition is not linked to high antioxidant activity
or total phenolics content (Cheplick et al., 2010).
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Aqueous extracts for samples of this study indicate a slightly higher inhibition
than ethanolic extracts. Even though α-amylase inhibition is considered to have positive
affects on prevention of hyperglycemia linked to type II diabetes, excess α- amylase
inhibition could lead to stomach distention and discomfort (Puls et al., 1977; Cheplick et
al., 2010). Moderate α-amylase inhibition and good α-glucosidase inhibition makes
family Apiaceae species good candidates for managing early stage hyperglycemia linked
to type II diabetes.
Figure 15 shows results for ethanolic extracts, which ranged from 0% (Ajowan) to
30% (Coriander). Antioxidant activity for aqueous extracts showed an inverse correlation
(r = -0.54) with α-amylase inhibition. Also, antioxidant activity for ethanolic extracts
demonstrated an inverse correlation (r = -0.66) with α-amylase inhibition. Correlations
between α-amylase and DPPH inhibition suggest that, total antioxidant activity does not
reflect the potential for α-amylase inhibition. This indicates that overall phenolic
antioxidants do not play any role in determining α-amylase inhibitory potential. It is also
possible that specific phenolics not present in species of family Apiaceae studied maybe
responsible or as suggested in previous studies (Kwon et al., 2006; Cheplick et al., 2010)
non-phenolic bioactives may be responsible. In general, managing hyperglycemia linked
to type II diabetes can be targeted through moderate α-amylase inhibition along with αglucosidase inhibition (Pinto et al., 2008). Therefore, Apiaceae family species such as
Dill and Ajowan might be considered good candidates for further in vivo studies to gain a
better insight on managing early stage hyperglycemia linked to type II diabetes. αAmylase inhibition of family Apiaceae, such as Dill and Caraway in aqueous and
ethanolic extracts also have potential of controlling blood glucose level in the context of
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preventing and managing type II diabetes through combinations of these condiments with
other whole foods with similar bioactive properties as in the case of Chilean potatoes.
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Figure 14 Changes observed in dose dependent (10 µL, 25 µL, 50 µL)) % α-amylase
inhibitory activities for aqueous extracts of Dill, Ajowan, Fennel, Caraway, Coriander
and Anise.
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Figure 15 Changes observed in dose dependent (10 µL, 25 µL, 50 µL)) % α-amylase
inhibitory activities for ethanolic extracts of Dill, Ajowan, Fennel, Caraway, Coriander
and Anise.
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4.2.5.4 ACE Inhibition

Hypertension is known to be a risk factor of various cardiovascular diseases and
is associated with long term diabetes (Kwon et al., 2006). In this study, we did not
observe ACE inhibitory activity for neither aqueous nor ethanolic extracts for family
Apiaceae. We suspect that, reason behind lack of ACE inhibition could be the use of
smaller amount of sample (2.5 g) to prepare extracts.

4.2.5.5 HPLC Analysis of Phenolic Phytochemicals

We observed 8 phenolic compounds in 6 selected species of family Apiaceae
based on the phenolic profile analysis using HPLC. The 8 phenolic compounds observed
include caffeic acid, catechin, rutin, chlorogenic acid, gallic acid, ferulic acid and
rosmarinic acid. The amounts (mg/g DW) and their standard error values are presented in
Table 4 and 5 for water and ethanol extracts. The content of caffeic acid in aqueous
extracts ranged from 0 mg/g (Coriander and Anise) to 3.93 mg/g (Fennel) of sample DW.
Caffeic acid in ethanolic extracts ranged from 0 mg/g (Dill and Ajowan) to 5.53 mg/g
(Anise) of sample DW. These results suggest that ethanolic and aqueous extracts have
specific phenolics in different species and in specific cases higher in ethanolic extracts.
Anise seeds do not have any bioactive caffeic acid in aqueous extract (0 mg/g DW) but
has higher content in its ethanolic extract (5.53 mg/g DW). Caffeic acid is known to be
naturally present in fruits and vegetables, and has anti-inflammatory and anti-oxidative
properties (Son and Lewis, 2002). Therefore, we can relate the actions of caffeic acid to

75

potentially help manage chronic oxidative diseases such as type II diabetes and
cardiovascular diseases.
The catechin content in aqueous extracts of various samples ranged from 0 mg/g
(Fennel, Caraway, Coriander and Anise) to 2.23 mg/g (Ajowan) of sample DW. Catechin
activity for ethanolic extracts ranged from 0 mg/g (Fennel, Caraway and Anise) to 1.26
mg/g (Ajowan) of sample DW.

Affect of catechin on human health has attracted

attention due to its antioxidant potential. It has been shown that ingestion of catechins is
known to decrease waist size while reducing body fat (Nagao et al., 2007). Even though
the amount of catechin observed is low, specific species from family Apiaceae has
potential of affecting energy and fat metabolism when incorporated in diet designs on
consistent basis along with other legumes, fruits and vegetables containing catechins.
The content of rutin in aqueous extracts ranged from 0 mg/g (Caraway and Anise)
to 27.6 mg/g (Dill) of sample DW. Rutin content in ethanolic extracts ranged from 0
mg/g (Fennel, Caraway and Anise) to 17.8 mg/g (Dill) of sample DW. The content of
Dill is the highest of any phenolic compounds found in the current study. Rutin is known
to have affects on dilating blood vessels and improving interpenetration of veins (Wang
et al., 2003). Rutin is found in many plants and is reported to have anti-inflammatory and
antioxidant activities. Rutin’s antioxidant activity is known to be responsible for many of
its bioactive activities (La Casa et al., 2000), such as preventing oxidative stress in
pancreatic beta cells which could lead to uncontrolled proliferation of damaged
pancreatic beta cells, increasing diabetes risk (Heineke et al., 1993). High amount of rutin
present in Dill species leads to the conclusion that, these samples could prove to have
protective affects against the development of type II diabetes and further in vivo studies
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would be needed based on incorporation of such condiments in a range of whole foods,
including potato and starch foods such as bread.
The content of chlorogenic acid in aqueous extracts ranged from 0 mg/g (Dill,
Ajowan and Anise) to 4.71 mg/g (Coriander) of sample DW. Chlorogenic acid content in
ethanolic extracts was only observed for anise, which was 2.78 mg/g of sample DW.
Chlorogenic acid is an antioxidant and potentially contributes in the prevention of
cardiovascular diseases and type II diabetes. The content of gallic acid was observed in
Caraway and Anise for aqueous extracts, which were 0.13 mg/g and 0.09 mg/g of sample
DW, respectively. The content of gallic acid in Caraway and Coriander for ethanolic
extracts was 1.02 mg/g and 0.55 mg/g of sample DW, respectively. Higher content of
gallic acid was found in ethanolic extracts of Caraway and Coriander than aqueous
extracts, but in general, a higher overall concentration was observed in aqueous extracts
of other species in this study. The content of p-coumaric acid and ferulic acid was very
low as indicated in Table 5. The content of rosmarinic acid in aqueous extracts ranged
from 0 mg/g (Fennel and Coriander) to 7.08 mg/g (Ajowan) of sample DW. The content
of rosmarinic acid in ethanolic extracts ranged from 0 mg/g (Caraway and Coriander) to
7.18 mg/g (Dill) of sample DW. Rosmarinic acid is a well known bioactive phenolic
compound targeted against oxidation-linked diseases (Shetty, 1997; Shetty and
Wahlqvist, 2004).
Presence of all the above phenolic compounds in seeds suggests that select
species of family Apiaceae in aqueous and ethanolic extracts have ability to provide
protection against oxidation-linked diseases. Such seed ingredients in whole food form
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can be used as condiments with a range of food designs for better dietary management of
hyperglycemia linked to type II diabetes.

Table 4 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Family
Apiaceae for Aqueous and Ethanolic Extracts. Analysis of Phenolic Compounds: Caffeic
Acid, Catechin, Rutin and Chlorogenic Acid.
Chlorogenic
Sample

Caffeic Acid

Catechin

Rutin
Acid

mg/g DW

mg/g DW

mg/g DW

H2O
Dill

1.62 ± 0.10

2.22 ± 0.14

27.6 ± 1.84

Ajowan

1.14 ± 0.03

2.23 ± 0.03

4.00 ± 0.52

Fennel

3.93 ± 0.03

Caraway

0.69 ± 0.02

5.37 ± 0.04

4.69 ± 0.03
2.99 ± 0.01

5.50 ± 0.15

Coriander

4.71 ± 0.06

Anise

ETHANOL
Dill

1.12 ± 0.40

17.8 ± 6.20

Ajowan

1.26 ± 0.23

3.26 ± 0.86

0.13 ± 0.00

1.25 ± 0.11

Fennel

1.56 ± 0.121

Caraway

0.88 ± 0.00

Coriander

0.90 ± 0.33

Anise

5.53 ± 2.07

2.78 ± 0.00
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Table 5 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Family
Apiaceae for Aqueous and Ethanolic Extracts. Analysis of Phenolic Compounds: Gallic
Acid, P-coumaric Acid, Ferulic Acid and Rosmarinic Acid.
Sample

Gallic Acid

p-coumaric acid

Ferulic Acid

Rosmarinic Acid

mg/g DW

mg/g DW

mg/g DW

mg/g DW

H2O
Dill

2.96 ± 0.18

Ajowan

7.08 ± 3.92

Fennel
Caraway

0.13 ± 0.00
0.15 ± 0.01

Coriander
Anise

1.09 ± 0.31
1.98 ± 0.03

0.09 ± 0.01

2.84 ± 0.00

ETHANOL
Dill

7.18 ± 0.00

Ajowan

2.32 ± 0.49

Fennel

1.65 ± 0.00

Caraway

1.02 ± 0.48

0.11 ± 0.00

Coriander

0.55 ± 0.03

0.24 ± 0.00

Anise

0.69 ± 0.00

0.82 ± 0.00

5.54 ± 1.74
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4.2.6

Conclusions

In this study, we have evaluated phenolic-linked anti-hyperglycemia potential of
seed phytochemicals of 6 select species of family Apiaceae with relevance for dietary
management of type II diabetes. Hot water and 12% ethanol extraction methods were
utilized to prepare samples used for further evaluation of their functionalities, using in
vitro assays. Total Soluble Phenolics, DPPH inhibition assay, α-glucosidase inhibition, αamylase inhibition and ACE inhibition were evaluated. Results indicated that there was
no ACE inhibition in any of the 6 selected species of family Apiaceae. α-Glucosidase
inhibition ranged upto 50%, and showed a large variation among samples. This
observation indicates that including Apiaceae family species in our diet would have
potential to manage hyperglycemia contributing potentially to overall prevention and
management of type II diabetes. Further, α-amylase inhibition was observed upto 30%, in
some species which indicates that select species from Apiaceae family could be helpful
towards controlling blood glucose levels preventing hyperglycemia. This research study
provides in vitro biochemical rationale of disease-linked functions of select seed
phytochemicals of the family Apiaceae, which provides the structure-function basis for in
vivo experiments for development of therapeutic strategies to help prevent chronic
hyperglycemia and associated complications linked to management of type II diabetes.
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4.3
Anti-Diabetic Potential of Select Middle Eastern Herbs of Family Lamiaceae
Using In Vitro Assays
4.3.1

Abstract

Emerging global trends indicate the use of bioactive compounds from plants as
sources of food and medicine for prevention and management of type II diabetes. In this
study, we screened 2 plant species of Lamiaceae family from the Near East Asia for its
total phenolic content and total antioxidant activity. In vitro functionality assays were
used to screen for α-glucosidase, α-amylase and angiotensin converting enzyme (ACE)
inhibitory activities to explore the biochemical relevance for management of
hyperglycemia and hypertension. Aqueous extracts of marjoram (41.1 mg/g DW) and
sage (38.4 mg/g DW) had higher total phenolic content compared to ethanolic extracts of
22.1 mg/g (Marjoram) and 16.7 mg/g (Sage). High α-glucosidase inhibitory activity was
observed for aqueous extracts of marjoram (86%) and sage (77%). High α-glucosidase
inhibition suggests that species from Lamiaceae family has potential to manage
hyperglycemia linked to type II diabetes.
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4.3.2

Introduction

Type II diabetes is considered as one of the most common metabolic disorders
worldwide and management of this epidemic is now targeting wide range of plants used
in food and medicine from local bioresources. Today, as many as 80% of the world
population relies on using traditional medicine for healthcare purposes (Muthu et al.,
2006). In the Middle East, wild edible plants have been used as a source of food and
medicine since ancient times. People from the Middle Eastern origin believe there is a
strong relationship between food and medicine (Dogan et al., 2004). Natural α-amylase
and α-glucosidase inhibitors from food grade plants offer cost effective and locally based
strategies to control postprandial hyperglycemia, and these inhibitors could be used in
therapies with minimum side effects (Kwon et al., 2006; Pinto et al., 2009). Plant sources
used as medicinal herbs have good potential over synthetic drugs due to low toxicity of
plants (Kwon et al., 2006).
Herbs are a rich source of phenolic phytochemicals having high antioxidant
activity (Kwon et al., 2006). High phenolic antioxidants from plants are highly correlated
with natural α-glucosidase inhibitors, and its presence increases the potential for
preventing hyperglycemia linked to on-set of type II diabetes. Plants such as Origanum
majorana (Marjoram) and Salvia libanotica (Sage) belongs to Lamiaceae family (Mint
Family), which also includes other plants such as rosemary and lavenders. Plants from
Lamiaceae family have commonly been used for food preservation, culinary flavors and
for treating common illnesses as traditional medicine (Shetty, 1997; Kwon et al., 2006).
Many plants and herbs related to Lamiaceae family have originated from the Middle East
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region in Asia. Lamiaceae family has aromatic characteristics and most of them are
grown for their essential oil producing tendencies. These herbs contain phenolic
phytochemicals, having therapeutic properties that are beneficial towards human health
(Shetty, 1997). Phenolic phytochemicals are associated with having potential for
managing chronic oxidation linked diseases, such as cardiovascular diseases and diabetes
(Shetty, 1997; Pinto and Shetty, 2010). Also, phytochemicals contain significant
antioxidant capacities which have potential to lower mortality rates of cancer in human
populations (Veioglu et al., 1998).
Free radicals play an important role in developing tissue damage in several
diseases such as metabolic syndrome diseases, cancer, neurodegenerative diseases and
pathological disorders (Erdemoglu et al., 2006). Antioxidants are known to play a crucial
part in prevention of many such diseases. Antioxidants inhibit the oxidation of lipids, by
inhibiting the propagation of oxidative chain reactions (Javanmardi et al., 2003).
Medicinal plants and herbs such as those species in the family Lamiaceae are an excellent
source of natural antioxidants used as spices and aromatic herbs. In particular, plants such
as sage, marjoram, thyme and rosemary are known to have strong antioxidant activity.
Salvia is the genera of plants that is considered one of the most diverse in Turkey with
many species, and has been used as traditional medicine to treat common colds and
stomach disorders (Cuvelier et al., 1996). Water extracts of sage are commonly used in
the Middle East to treat common colds, coughs and as anti-inflammatory agent in oral
cavity (Farhat et al., 2001). Studies have shown that essential oils of this plant has
antibacterial effects, as well as suppressive activities against tumor formation (Hilan et
al., 1997; Farhat et al., 2001) Origanum majorana commonly known as marjoram, is also
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rich in essential oils and also characterized with high content of phenolic compounds.
Marjoram is commonly used in the Middle East as folk medicine, particularly in the form
of tea as a prescription for fever, sinus congestion and nervous disorders (Qari, 2008).
Marjoram is known for its potent antioxidant and antimicrobial activities similar to sage.
Marjoram consists of anti-hepatoma and anti-genotoxicity activities, based on the
indication that it reduces number of cell and chromosomal aberrations (Qari, 2008).
These characteristics of marjoram could play an important preventive role in occurrence
of type II diabetes. Pancreatic beta cells could be damaged due to oxidative stress before
they are replicated or proliferated. If damaged pancreatic beta cells are prevented from
proliferating through cell repair and apoptosis, then the possibility of incidence of
diabetes from occurring could be reduced. Therefore, the inclusion of herbal food sources
in our diet could help manage hyperglycemia in early stages which is linked to long term
diabetes from further defects in pancreatic cells from hyperglycemia-linked oxidative
damage.
Therefore the objective of this research study was to screen 2 species belonging to
Lamiaceae family from the Near East Asia region for their total phenolic content and
total antioxidant activity. Following these studies, in vitro assays such as α-amylase, αglucosidase and ACE inhibitory activities were evaluated. These in vitro assays would
provide biochemical rationale for use of sage and marjoram in prevention of
hyperglycemia and hypertension linked to type II diabetes. Also, we determined
individual phenolic compounds found in phenolic profile by HPLC. This would allow us
to correlate phenolic compounds of herbs to total antioxidant activity and total soluble
phenolics content and link it to specific health relevant functional activity.
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4.3.3

Materials and Methods

4.3.3.1 Materials

Dried herb sample of Origanum majorana (Marjoram) and Salvia libanotica
(Sage) were obtained from the Department of Biology of United Arab Emirates
University, Al-Ain, UAE. Porcine pancreatic α-amylase (EC 3.2.1.1), rat intestinal αglucosidase (EC 3.2.1.20), hippuric acid, 2,2-diphenyl-1-picrylhydrazyl (DPPH), rabbit
lung ACE (EC 3.4.15.1), cinnamic acid, rosmarinic acid, protocatechuic acid, p-coumaric
acid, chlorogenic acid, caffeic acid, ferulic acid, and quercetin were purchased from
Sigma Chemical Co. (St. Louis, MO).

4.3.3.2 Sample Preparation

Water Extracts:
The samples (2.5 g) were extracted in 100 mL of distilled water under reflux at
95°C for 30 minutes. The samples were centrifuged for 10 minutes and stored in a
refrigerator at -20°C until analysis, for no more than 1 week.

Ethanol extracts:
The samples (2.5 g) were extracted in 100 mL of 12% ethanol in a shaker at a
speed of 150 RPM overnight at 20°C. The samples were filtered and stored in a
refrigerator at –20°C until analysis, for no more than 1 week.
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4.3.3.3 Total Phenolic Assay

The total phenolics in all samples were determined by using a method modified
by Shetty et al. (1995). In brief, 0.5 mL of sample extract was added to a test tube and
mixed with 0.5 mL of 95% ethanol and 5 mL of distilled water. To each sample, 0.5 mL
of 50% (vol/vol) Folin-Ciocalteu reagent was added and mixed. The absorbance was read
at 725 nm using a spectrophotometer (Genesys UV/Visible, Milton Roy, Inc., Rochester,
NY). Different concentrations of gallic acid were used to develop a standard curve.
Results were expressed as mg of gallic acid/g of sample dry weight (DW).

4.3.3.4 Antioxidant Activity by DPPH Radical Inhibition Assay

The antioxidant activity was determined by the DPPH radical scavenging method
modified from Kwon et al. (2006). A 250-μL aliquot of the sample extract was mixed
with 1,250 μL of DPPH (60 μM in ethanol). The mixture was centrifuged at 13,000 g for
1 minute, and after this the absorbance was measured at 517 nm using the Genesys
UV/Visible spectrophotometer. The readings were compared with the controls,
containing 95% ethanol instead of sample extract. The percentage inhibition was
calculated by:

% inhibition =

(Absorbancecontrol − Absorbanceextract )
×100
Absorbancecontrol
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4.3.3.5 α-Amylase Inhibition Assay

The α-amylase inhibitory activity was determined by an assay modified from the
Worthington Enzyme Manual (Worthington, 1993). A total of 500 µL of sample extract
and 500 µL of 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M NaCl) containing
α-amylase solution (0.5 mg/mL) were incubated at 25°C for 10 minutes. After
preincubation, 500 µL of a 1% starch solution in 0.02 M sodium phosphate buffer (pH
6.9 with 0.006 M NaCl) was added to each tube at timed intervals. The reaction was
stopped with 1.0 mL of dinitrosalicylic acid color reagent. The test tubes were incubated
in a boiling water bath for 5 minutes and cooled to room temperature. The reaction
mixture was then diluted after adding 5-15 mL of distilled water, and the absorbance was
measured at 540 nm using the Genesys UV/Visible spectrophotometer. The readings
were compared with the controls, containing buffer instead of sample extract. The
percentage α-amylase inhibitory activity was calculated with the same equation as for
percentage inhibition in the DPPH radical inhibition assay.

4.3.3.6 α-Glucosidase Inhibition Assay

The α-glucosidase inhibitory activity was determined by an assay modified from
McCue et al. (2005). α-Glucosidase was assayed by using 50 μL of sample extracts and
100 μL of 0.1 M phosphate buffer (pH 6.9) containing α-glucosidase solution (1 U/mL)
and was incubated in 96-well plates at 25°C for 10 min. After preincubation, 50 μL of 5
mM p-nitrophenyl-α-d-glucopyranoside solution in 0.1 M phosphate buffer (pH 6.9) was
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added to each well at timed intervals. The reaction mixtures were incubated at 25°C for 5
min. Before and after incubation, absorbance readings were recorded at 405 nm by a
microplate reader (Thermomax, Molecular Devices Co., Sunnyvale, CA) and compared
to a control that had 50 μL of buffer solution in place of the extract. The α-glucosidase
inhibitory activity was expressed as percentage inhibition and was calculated with the
same equation as for percentage inhibition in the DPPH radical inhibition assay. Dose
dependency was tested using 10 µL and 25 µL of the sample, the volume made up to 50
µL using 0.1 M phosphate buffer (pH 6.9) and same protocol was followed.

4.3.3.7 ACE Inhibition Assay

ACE inhibition was assayed by a method modified by Kwon et al. (2006). The
substrate hippuryl-histidyl-leucine (HHL) and the enzyme ACE-I from rabbit lung (EC
3.4.15.1) were used. Fifty μL of sample extracts were incubated with 100 μL of 1 M
NaCl-borate buffer (pH 8.3) containing 2 mU of ACE-I solution at 37°C for 10 min.
After preincubation, 100 μL of a 5 mU substrate (HHL) solution was added to the
reaction mixture. Test solutions were incubated at 37°C for 1 hour. The reaction was
stopped with 150 μL of 0.5 N HCl. Five μl of the sample was injected in a highperformance liquid chromatography (HPLC) apparatus (Agilent 1100 series equipped
with autosampler and DAD 1100 diode array detector, Agilent Technologies, Palo Alto,
CA). The solvents used for gradient were (1) 10 mM phosphoric acid (pH 2.5) and (2)
100% methanol. The methanol concentration was increased to 60% for the first 8 min and
to 100% for 5 min and then was decreased to 0% for the next 5 min (total run time, 18
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min). The analytical column used was an Agilent Nucleosil 100-5C18, 250 mm × 4.6 mm
inside diameter, with packing material of 5 μm particle size at a flow rate of 1 ml/min at
ambient temperature. During each run, the absorbance was recorded at 228 nm, and the
chromatogram was integrated using the Agilent Chemstation (Agilent Technologies)
enhanced integrator for detection of liberated hippuric acid (A). Hippuric acid standard
was used to calibrate the standard curve and retention time. The percentage inhibition
was calculated by:

% inhibition =

(Acontrol − Aextract )
×100
(Acontrol − Ablank )

4.3.3.8 HPLC Analysis of Phenolic Phytochemicals

Two milliliters of the extracts was filtered (pore size, 0.2 μm), and 5 μL was
injected in the HPLC apparatus (Agilent 1100 series equipped with autosampler and
DAD 1100 diode array detector). The solvents used for gradient elution were (A) 10 mM
phosphoric acid (pH 2.5) and (B) 100% methanol. The methanol concentration was
increased to 60% for the first 8 minutes and to 100% over the next 7 minutes, then
decreased to 0% for the next 3 minutes, and maintained for the next 7 minutes (total run
time, 25 minutes). The analytical column used was an Agilent Zorbax SB-C18, 250 mm
× 4.6 mm i.d., with packing material of 5 μm particle size at a flow rate of 1 mL/minute
at ambient temperature. During each run the absorbance was recorded at 306 nm and 333
nm, and the chromatogram was integrated using the Agilent Chemstation enhanced
integrator. Calibration was performed by injecting the standards of cinnamic acid,
rosmarinic acid, protocatechuic acid, p-coumaric acid, chlorogenic acid, caffeic acid,
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ferulic acid, and quercetin. Peak identification was performed by comparison of retention
times and diode array spectral characteristics with the standards. The results were
expressed as μg/g of sample DW.

4.3.3.9 Statistical Analysis

All experiments were performed in either duplicates or triplicates. Analysis at
every time point from each experiment was carried out in duplicate or triplicate. Means,
standard errors and standard deviations were calculated from replicates within the
experiments and analyzed using Microsoft Excel XP.
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4.3.4

Results and Discussion

4.3.4.1 Total Phenolics and Antioxidant Activity by DPPH Inhibition

In this study, we focused on aqueous and ethanolic extracts of two species
common to Near East regions of Asia belonging to Lamiaceae family. Samples were
screened for their anti-hyperglycemia and anti-hypertension potential based on in vitro
assays relevant to development of biochemical rationale for management of type II
diabetes in the early stages. Figure 16 shows the total phenolic content of aqueous
extracts for Origanum majorana (Marjoram) and Salvia libanotica (Sage). Total phenolic
content for aqueous extract of marjoram was observed to be 41.15 mg/g of sample dry
weight (DW), and sage was 38.4 mg/g of sample DW. Total phenolic content observed
for ethanolic extracts of sage and marjoram was lower than that observed for aqueous
extracts. High concentration of phenolic phytochemicals observed in oregano previously
suggests that it has high antioxidant and antimicrobial activity (Chun et al., 2005). Figure
17 shows phenolic content for ethanolic extracts of marjoram (22.15 mg/g of sample
DW) and sage (16.7 mg/g of sample DW). Extraction process for aqueous extracts was
carried out under higher temperatures than ethanolic extracts, and therefore resulted in
higher extractable phenolic content for marjoram and sage (Seaberg et al., 2003; Chun et
al., 2005). The high phenolic content indicates the relevance for hyperglycemia linked to
type II diabetes (Kwon et al., 2006). High phenolic content indicates the potential of
ingestion of sage and marjoram in various food designs and combinations to slow down
and delay in development of type II diabetes.
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Total antioxidant activity measured by DPPH inhibition assay indicated similar
results for aqueous and ethanolic samples of sage and marjoram, although the phenolic
content showed a difference (Figure 16 & 17). The % inhibition of DPPH ranged from
76.6% to 79.6% for aqueous and ethanolic extracts of the samples. This suggests that
total phenolic content may not be totally important in determining antioxidant activity of
the extracts, but the physico-chemical nature of individual phenolics may play a part
(Chun et al., 2005). Figure 16 shows the results obtained for total antioxidant activity by
DPPH assay for aqueous extracts of Origanum majorana (Marjoram) and Salvia
libanotica (Sage), with a correlation of total phenolic content. Total antioxidant activity
measured for aqueous extracts of marjoram was observed to be 77.5% DPPH inhibition,
which was lower than that observed for sage (79%). There was no significant difference
seen between the two Lamiaceae samples because of their similar phytochemical
compositions, but the polyphenol content was higher in aqueous extracts of sage. Figure
17 shows the total antioxidant activity observed for ethanolic extracts of Origanum
majorana (Marjoram) and Salvia libanotica (Sage). The % DPPH inhibition measured for
ethanolic extracts of marjoram (79.6%) was higher compared to aqueous extracts. Total
antioxidant activity observed for sage (76.6%) was lower than the value observed for
aqueous extracts. High % DPPH inhibition of sage and marjoram indicates that, total
phenolic content in this case cannot be the basis of prediction for total antioxidant activity
(Kahkonen et al., 1999; Parejo et al., 2002). Total phenolic content for aqueous extracts
indicated an inverse (r = -1) correlation with % DPPH inhibition. But, a high correlation
(r = 1) was observed between total phenolic content and % DPPH inhibition for ethanolic
extracts. High antioxidant activity of sage and marjoram suggests that, plant derived
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additives from herbs and spices could prove to be beneficial towards prevention of
oxidative stress, and could be potentially beneficial in managing the micro vascular
complications of type II diabetes (Kwon et al., 2006). Such findings could prove that,
substitution of plant extracts for synthetic food antioxidants has potential to influence
human health (Martinez-Tome et al., 2001; Hinneburg et al., 2006). Total phenolic
content and total antioxidant activity by DPPH assay indicates that these plants, which
are commonly consumed in Mediterranean diet (Parejo et al., 2002), can prove to be
protective against oxidative stress with cross-over beneficial affects on human health.
These herbs could prove to have potential to be industrially efficient due to their high
phenolic antioxidant activity, which helps in slowing down oxidative degradation of
lipids (Wojdylo et al., 2007), and improving the quality and nutritional value of food.
High total antioxidant activity measured via DPPH assay also indicates the potential that
these antioxidants might play an important part in suppressing oxidative stress caused to
pancreatic beta cell function, which may reduce the incidence of type II diabetes (Song et
al., 2005; Bhandari et al., 2008). Therefore, it can be concluded that, specific phenolic
compounds responsible for high antioxidant activity may serve as a preventive measure
against the development of type II diabetes, if applied through better food designs and
combinations for dietary management in early stages.
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Figure 16 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total
Antioxidant Activity (% DPPH Inhibition ± Standard Error) correlation of aqueous
extracts of Origanum majorana (Marjoram) and Salvia libanotica (Sage).
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Figure 17 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total
Antioxidant Activity (% DPPH Inhibition ± Standard Error) correlation of ethanolic
extracts of Origanum majorana (Marjoram) and Salvia libanotica (Sage).
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4.3.4.2 α–Glucosidase Inhibition

Type II diabetes is growing rapidly globally mainly due to the diet and lifestyle
changes leading to obesity in general population. A therapeutic approach to decrease
postprandial hyperglycemia is by slowing the absorption of glucose, by inhibition of
α-glucosidase enzyme in digestive system (Bhandari et al., 2008). Therefore, we
investigated inhibitory activity of α-glucosidase inhibitors in aqueous and ethanolic
extracts of sage and marjoram.
Dose dependency studies (10µl, 25µl, 50µl) indicated dose dependent responses,
where the highest inhibition was observed for samples with no dilution and the lowest
inhibition was seen for 1/5 diluted samples. Therefore as the sample dilution
increased, % inhibition was seen to decrease. Figure 18 indicates results for dose
dependent studies using extracts of sage and marjoram, which ranged from 55%
(Sage, 1/5 dilution sample) to 85.6% (Marjoram, no dilution sample). Aqueous
extracts of marjoram indicated higher α-glucosidase inhibitory activity than sage in
all dose dependent studies of sample extracts. Aqueous extracts of sage and marjoram
had a high α-glucosidase inhibitory activity, which also had a high content of
rosmarinic acid (Table 6). Total phenolic content for aqueous extracts showed a high
correlation (r = 1) with α-glucosidase inhibition. This suggests that there may be
some specific phenolic compounds which could be responsible for high αglucosidase inhibitory activity of the sample extracts. Total phenolic content for
ethanolic extracts showed an inverse correlation (r = -1) with α-glucosidase inhibitory
activity. Unlike aqueous extracts of the samples, where a high correlation was seen
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for total phenolic content and α-glucosidase inhibition, ethanolic extracts showed
opposite results with no correlation. The phenolic profile of ethanolic extracts (Table
1), low content of rosmarinic acid was observed, but the content of rutin was
observed to be higher for sage compared to aqueous extracts, where no rutin content
was found. Therefore, based on the results we can suggest that, Lamiaceae samples
with phenolic compound such as rosmarinic acid, caffeic acid and rutin could
potentially contain hypoglycemic affects due to their high α-glucosidase inhibitory
activities.
Figure 19 shows the results for α-glucosidase inhibition for ethanolic extracts of
sage and marjoram. Compared to aqueous extracts of the samples, ethanolic extracts
showed higher α-glucosidase inhibitory activity for sage, which ranged from 69%
(1/5 sample dilution) to 79% (no sample dilution). These results suggest that,
inhibitory activity for sage could potentially be higher in ethanolic extracts due to a
certain phenolic compounds being efficiently extracted that are not present in aqueous
extracts, such as rutin (Table 6). Inhibitory activity for marjoram was observed to be
lower than aqueous extracts, which ranged from 62.6% (1/5 sample dilution) to 70%.
Correlations between DPPH assay and α-glucosidase inhibition illustrates an inverse
activity (r = -1) for both aqueous and ethanolic extracts. This suggests that,
antioxidant activity may not totally affect the α-glucosidase inhibitory activity of
these Lamiaceae samples, even though the percent inhibitory activities were seen to
be higher for both assays. High α-glucosidase inhibitory activity suggests that, sage
and marjoram have anti-diabetic potentials observed in both aqueous and ethanolic
extracts. Results for sage and marjoram varied for ethanolic and aqueous extracts,
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with higher inhibition for marjoram in aqueous extracts and being high for sage in
ethanolic extracts. Therefore, we can assume that, enrichment of Lamiaceae herbs in
our diet through condiments or other ways could result in enhancement of our health
through functional bioactive enrichment of foods. This could be seen in terms of αglucosidase inhibition relevant to hyperglycemia which is linked to type II diabetes
management. Lamiaceae species such as sage and marjoram have high α-glucosidase
inhibitory activities for both ethanolic and aqueous extracts, suggesting that the
inclusion of these high phenolic herbs in our diet could help reduce blood glucose
levels and lengthen the duration of carbohydrate absorption (Ye et al., 2002; Kwon et
al., 2006). Lowering of blood glucose level to normal is the most important part of
treating persistent hyperglycemia, which is the characteristic of type II diabetes (Ye et
al., 2002). Synthetic forms of α-glucosidase inhibitors are known to come with
various side effects, and toxicity being one of them, is allowing people to explore
alternative strategies, such as developing natural plant food-based strategies through
effective dietary management. Therefore, natural forms of α-glucosidase inhibitors
present in sage and marjoram could serve potentially to be an important way to
suppress elevated blood glucose levels, due to hyperglycemia linked to the incidence
of type II diabetes.
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Figure 18 Changes observed in dose dependent (10 µL, 25 µL, 50 µL) % α-glucosidase
inhibitory activities for aqueous extracts of Origanum majorana (Marjoram) and Salvia
libanotica (Sage).

100
90
80

% Inhibition

70
60

1/5 Dilution

50

1/2 Dilution

40

No Dilution

30
20
10
0
O.majorana

S.libanotica
Sample (Dilution)

Figure 19 Changes observed in dose dependent (10 µL, 25 µL, 50 µL) % α-glucosidase
inhibitory activities for ethanolic extracts of Origanum majorana (Marjoram) and Salvia
libanotica (Sage).
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Table 6 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Lamiaceae
Family for Aqueous and Ethanolic Extracts. Analysis of Phenolic Compounds:
Rosmarinic Acid, Caffeic Acid and Rutin.

Sample

Rosmarinic

Caffeic

Acid

Acid

Rutin

mg/g DW

mg/g DW

mg/g DW

H2O
Origanum
majorana

27.4 ± 0.72

Salvia libanotica

39.7 ± 0.53

2.73 ± 0.14

majorana

5.13 ± 3.32

8.00 ± 1.15

Salvia libanotica

2.60 ± 0.12

ETHANOL
Origanum

15.0 ± 0.40

4.3.4.3 α-Amylase Inhibition

α-Amylase serves a role similar to α-glucosidase, by managing hyperglycemia
linked to type II diabetes (Pinto et al., 2009). In vitro α-amylase inhibition was
evaluated for ethanolic and aqueous extracts of Origanum majorana (Marjoram) and
Salvia libanotica (Sage). No α-amylase inhibition was observed for either extracts of
both samples. Sage and marjoram may not have some specific compounds present,
which could cause it modulate α-amylase inhibition (Kwon et al., 2006). Though the
samples did not indicate any α-amylase inhibition, but high α-glucosidase inhibition
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suggests that it could still serve as a food ingredient and condiment that can be used
to help manage hyperglycemia linked to type II diabetes.

4.3.4.4 ACE Inhibition

Hypertension is a risk factor for the advancement of cardiovascular diseases,
which is a long term macro vascular complication of type II diabetes (Kwon et al., 2006).
Development of natural food sources to help manage hypertension is of interest and a
lower cost option. There was no ACE inhibition observed for the select species of family
Lamiaceae in this study. We suspect that the reason behind not observing ACE inhibition
for Lamiaceae samples could be due to the amount of sample (2.5g), which was used to
prepare sample extracts. We can assume that, total phenolic content and total antioxidant
activity did not influence the results obtained for ACE inhibition. This suggests that there
may be other phenolic compounds or peptides not enriched in these extracts linked to
ACE inhibition of sage and marjoram. (Kwon et al., 2006)

4.3.4.5 HPLC Analysis of Phenolic Phytochemicals

Three different major phenolic compounds were observed in ethanolic and
aqueous extracts of Origanum majorana (Marjoram) and Salvia libanotica (Sage). These
compounds include rosmarinic acid, caffeic acid and rutin, and amounts (mg/g DW) and
their standard errors are indicated in Table 7, for both aqueous and ethanolic extracts.
Rosmarinic acid observed for aqueous extracts of sage and marjoram showed a higher
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content than ethanolic extracts. Rosmarinic acid content for aqueous extracts ranged from
27.4 mg/g (Marjoram) to 39.7 mg/g (Sage) of sample DW, where it ranged from 2.6 mg/g
(Sage) to 5.1 mg/g (Marjoram) for ethanolic extracts. Rosmarinic acid is abundantly
found in plants belonging to Lamiaceae family (Shetty, 1997; Peterson and Simmonds,
2003). Rosmarinic acid is known to provide protection against cancer and contains high
antioxidant activity (Peteron and Simmonds, 2003), which may be the reason a high total
antioxidant activity was observed for sage and marjoram. Presence of this particular
phenolic compound in our diet as a natural food source would have the potential to
manage hyperglycemia and associated obesity, preventing the incidence of type II
diabetes. Additional in vivo studies are needed to understand the antioxidant, antiinflammatory and anti-diabetic chemopreventive affects of rosmarinic acid from
Lamiaceae plants on human health using optimized whole food extracts.
The content of phenolic compound, caffeic acid was observed in both aqueous
and ethanolic extracts of the samples. The content in sage was 2.7 mg/g DW in the
aqueous extracts, and marjoram 8 mg/g DW in ethanolic extracts. Caffeic acid is known
to play an important part in fruits and vegetables as an antioxidant, due to which we
relate its actions for potential prevention of chronic illnesses such as cardiovascular
diseases and cancer. Another phenolic compound that we observed in ethanolic extracts
of marjoram was rutin. Rutin content was 15 mg/g of sample DW. Phenolic flavonoids
such as rutin, are commonly found in many fruits and vegetables, and are used to provide
protection against development of vascular diseases (Schramm and German, 1998). This
gives us some evidence on how the presence of rutin in ethanolic extract of sage could
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prove to be potentially beneficial towards managing hypertension linked to type II
diabetes though in vitro studies did not indicate such activity in this investigation.

Table 7 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Lamiaceae
Family for Aqueous and Ethanolic Extracts. Analysis of Phenolic Compounds:
Rosmarinic Acid, Caffeic Acid and Rutin.

Sample

Rosmarinic

Caffeic

Acid

Acid

Rutin

mg/g DW

mg/g DW

mg/g DW

H2O
Origanum
majorana

27.4 ± 0.72

Salvia libanotica

39.7 ± 0.53

2.73 ± 0.14

majorana

5.13 ± 3.32

8.00 ± 1.15

Salvia libanotica

2.60 ± 0.12

ETHANOL
Origanum

15.0 ± 0.40
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4.3.5

Conclusions

Main focus of this research study was to evaluate anti-hyperglycemia and
antihypertensive potential of 2 select species (Origanum majorana and Salvia
libanotica), of Lamiaceae family common in Near East of Asia. Samples were prepared
through hot water and 12% ethanol extractions. In vitro functionality assays such as total
soluble phenolics and inhibition assays like DPPH, α-glucosidase, α-amylase and ACE
were evaluated for these select herbs to explore potential for hyperglycemic and
hypertensive management. No ACE and α-amylase inhibition was observed for sage and
marjoram, which could be due to absence of certain phenolic compounds in evaluated
samples. α-Glucosidase inhibition for ethanolic and aqueous extracts of select samples
ranged from 55% (Sage, 1/5 dilution sample) to 85.6% (Marjoram, no dilution sample).
High α-glucosidase inhibition activity indicates that inclusion of herbs from Lamiaceae
family could potentially help manage hyperglycemia linked to type II diabetes. Total
phenolic content ranged upto 41.1 mg/g of sample DW, along with high DPPH inhibition
which ranged upto almost 80%. High phenolic antioxidant activity suggests that certain
phenolic compounds are present in select species, which could prove to be beneficial
towards human health if included as part of food designs for a healthy diet. This research
provides biochemical rationale for clinical studies on functional benefits of sage and
marjoram from Lamiaceae family, which could further be applied in in vivo studies for
development and innovation of therapeutic strategies, to prevent and manage type II
diabetes.
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